메뉴 건너뛰기




Volumn 122, Issue 3, 2002, Pages 1037-1057

Prognostic factors in non-small cell lung cancer: A decade of progress

Author keywords

Carcinoma; Multivariate analysis; Non small cell lung cancer; Prognosis

Indexed keywords

ADVANCED CANCER; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; DATA BASE; ENVIRONMENT; HOST; HUMAN; LUNG NON SMALL CELL CANCER; MEDICAL LITERATURE; MEDLINE; MULTIVARIATE ANALYSIS; PATIENT CARE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; STATISTICAL ANALYSIS;

EID: 0036384579     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.122.3.1037     Document Type: Review
Times cited : (531)

References (290)
  • 1
    • 0001163006 scopus 로고    scopus 로고
    • Cancer of the lung
    • DeVita VT, Hellman S, Rosenberg SA, eds. Philadelphia, PA: Lippincott-Raven
    • Ginsberg RJ, Vokes EE, Raben A. Cancer of the lung. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: principles and practice of oncology. Philadelphia, PA: Lippincott-Raven, 1999; 849-950
    • (1999) Cancer: Principles and Practice of Oncology , pp. 849-950
    • Ginsberg, R.J.1    Vokes, E.E.2    Raben, A.3
  • 2
    • 0027941826 scopus 로고
    • Variation in the management and outcome of non-small cell lung cancer in Ontario
    • Mackillop WJ, Zhou Y, Dixon P, et al. Variation in the management and outcome of non-small cell lung cancer in Ontario. Radiother Oncol 1994; 32:106-115
    • (1994) Radiother Oncol , vol.32 , pp. 106-115
    • Mackillop, W.J.1    Zhou, Y.2    Dixon, P.3
  • 3
    • 0015306697 scopus 로고
    • Clinical biostatistics XIV: The purposes of prognostic stratification
    • Feinstein AR. Clinical biostatistics XIV: the purposes of prognostic stratification. Clin Pharmacol Ther 1972; 13:285-297
    • (1972) Clin Pharmacol Ther , vol.13 , pp. 285-297
    • Feinstein, A.R.1
  • 4
    • 0035281919 scopus 로고    scopus 로고
    • Phase I study of a decision aid for patients with locally advanced non-small cell lung cancer
    • Brundage MD, Feldman-Stewart D, Cosby R, et al. Phase I study of a decision aid for patients with locally advanced non-small cell lung cancer. J Clin Oncol 2001; 19:1326-1335
    • (2001) J Clin Oncol , vol.19 , pp. 1326-1335
    • Brundage, M.D.1    Feldman-Stewart, D.2    Cosby, R.3
  • 5
    • 0002124406 scopus 로고    scopus 로고
    • The importance of prognosis in cancer medicine
    • Gospodarowicz MK, Henson DE, Hutter RBP, et al, eds. New York, NY: Wiley & Sons
    • Mackillop WJ. The importance of prognosis in cancer medicine. In: Gospodarowicz MK, Henson DE, Hutter RBP, et al, eds. Prognostic factors in cancer. New York, NY: Wiley & Sons, 2001
    • (2001) Prognostic Factors in Cancer
    • Mackillop, W.J.1
  • 6
    • 0028048944 scopus 로고
    • Prognostic factors in lung cancer: Tables and comments
    • Buccheri G, Ferrigno D. Prognostic factors in lung cancer: tables and comments. Eur Respir J 1994; 7:1350-1364
    • (1994) Eur Respir J , vol.7 , pp. 1350-1364
    • Buccheri, G.1    Ferrigno, D.2
  • 7
    • 0027972129 scopus 로고
    • Prognostic factors in non-small cell lung cancer
    • Feld R, Borges M, Giner V, et al. Prognostic factors in non-small cell lung cancer. Lung Cancer 1994; 11(suppl):S19-S23
    • (1994) Lung Cancer , vol.11 , pp. S19-S23
    • Feld, R.1    Borges, M.2    Giner, V.3
  • 8
    • 0029885852 scopus 로고    scopus 로고
    • New prognostic factors in resectable non-small cell lung cancer
    • Smit EF, Groen HJ, Splinter TA, et al. New prognostic factors in resectable non-small cell lung cancer. Thorax 1996; 51:638-646
    • (1996) Thorax , vol.51 , pp. 638-646
    • Smit, E.F.1    Groen, H.J.2    Splinter, T.A.3
  • 9
    • 0029046361 scopus 로고
    • New prognostic factors in lung cancer: Biologic prophets of cancer cell aggression
    • Mountain CF. New prognostic factors in lung cancer: biologic prophets of cancer cell aggression. Chest 1995; 108:246-254
    • (1995) Chest , vol.108 , pp. 246-254
    • Mountain, C.F.1
  • 10
    • 0030912190 scopus 로고    scopus 로고
    • Revisions in the international system for staging lung cancer
    • Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997; 111:1710-1717
    • (1997) Chest , vol.111 , pp. 1710-1717
    • Mountain, C.F.1
  • 11
    • 84971581087 scopus 로고
    • Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials
    • Stewart LA, Pignon JP. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ 1995; 311:899-909
    • (1995) BMJ , vol.311 , pp. 899-909
    • Stewart, L.A.1    Pignon, J.P.2
  • 12
    • 0025826624 scopus 로고
    • Survival determinants in extensive-stage non-small-cell lung cancer: The Southwest Oncology Group experience
    • Albain KS, Crowley JJ, LeBlanc M, et al. Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience. J Clin Oncol 1991; 9:1618-1626
    • (1991) J Clin Oncol , vol.9 , pp. 1618-1626
    • Albain, K.S.1    Crowley, J.J.2    LeBlanc, M.3
  • 13
    • 0029030143 scopus 로고
    • Prognostic factors for survival in advanced non-small-cell lung cancer: Univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients: The European Lung Cancer Working Party
    • Paesmans M, Sculier JP, Libert P, et al. Prognostic factors for survival in advanced non-small-cell lung cancer: univar-iate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients: the European Lung Cancer Working Party. J Clin Oncol 1995; 13:1221-1230
    • (1995) J Clin Oncol , vol.13 , pp. 1221-1230
    • Paesmans, M.1    Sculier, J.P.2    Libert, P.3
  • 14
    • 0029588645 scopus 로고
    • Survival predictors in advanced non-small cell lung cancer
    • Hespanhol V, Queiroga H, Magalhaes A, et al. Survival predictors in advanced non-small cell lung cancer. Lung Cancer 1995; 13:253-267
    • (1995) Lung Cancer , vol.13 , pp. 253-267
    • Hespanhol, V.1    Queiroga, H.2    Magalhaes, A.3
  • 15
    • 0030220305 scopus 로고    scopus 로고
    • Prognostic factors for patients with advanced non-small cell lung cancer: Univariate and multivariate analyses including recursive partitioning and amalgamation
    • Takigawa N, Segawa Y, Okahara M, et al. Prognostic factors for patients with advanced non-small cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation. Lung Cancer 1996; 15:67-77
    • (1996) Lung Cancer , vol.15 , pp. 67-77
    • Takigawa, N.1    Segawa, Y.2    Okahara, M.3
  • 16
    • 0025761204 scopus 로고
    • Quality of life assessment: An independent prognostic variable for survival in lung cancer
    • Ganz PA, Lee JJ, Siau J. Quality of life assessment: an independent prognostic variable for survival in lung cancer. Cancer 1991; 67:3131-3135
    • (1991) Cancer , vol.67 , pp. 3131-3135
    • Ganz, P.A.1    Lee, J.J.2    Siau, J.3
  • 17
    • 0030757244 scopus 로고    scopus 로고
    • Quality of life in oncology practice: Prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy
    • Coates A, Porzsolt F, Osoba D. Quality of life in oncology practice: prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy. Eur J Cancer 1997; 33:1025-1030
    • (1997) Eur J Cancer , vol.33 , pp. 1025-1030
    • Coates, A.1    Porzsolt, F.2    Osoba, D.3
  • 18
    • 0032916512 scopus 로고    scopus 로고
    • Is quality of life predictive of the survival of patients with advanced nonsmall cell lung carcinoma?
    • Herndon JE, Fleishman S, Kornblith AB, et al. Is quality of life predictive of the survival of patients with advanced nonsmall cell lung carcinoma? Cancer 1999; 85:333-340
    • (1999) Cancer , vol.85 , pp. 333-340
    • Herndon, J.E.1    Fleishman, S.2    Kornblith, A.B.3
  • 19
    • 0035144762 scopus 로고    scopus 로고
    • Quality of life in lung cancer patients: As an important prognostic factor
    • Montazeri A, Milroy R, Hole D, et al. Quality of life in lung cancer patients: as an important prognostic factor. Lung Cancer 2001; 31:233-240
    • (2001) Lung Cancer , vol.31 , pp. 233-240
    • Montazeri, A.1    Milroy, R.2    Hole, D.3
  • 20
    • 0034176511 scopus 로고    scopus 로고
    • The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy
    • Langendijk H, Aaronson NK, de Jong JM, et al. The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy. Radiother Oncol 2000; 55:19-25
    • (2000) Radiother Oncol , vol.55 , pp. 19-25
    • Langendijk, H.1    Aaronson, N.K.2    De Jong, J.M.3
  • 21
    • 85007195355 scopus 로고
    • Lung
    • Perez CA, ed. Philadelphia, PA: Lippincott
    • Emami B, Perez CA. Lung. In: Perez CA, ed. Radiation oncology. Philadelphia, PA: Lippincott, 1993
    • (1993) Radiation Oncology
    • Emami, B.1    Perez, C.A.2
  • 22
    • 0022979539 scopus 로고
    • Factors affecting survival in superior sulcus tumors
    • Anderson TM, Moy PM, Holmes EC. Factors affecting survival in superior sulcus tumors. J Clin Oncol 1986; 4:1598-1603
    • (1986) J Clin Oncol , vol.4 , pp. 1598-1603
    • Anderson, T.M.1    Moy, P.M.2    Holmes, E.C.3
  • 24
    • 0030761847 scopus 로고    scopus 로고
    • Pancoast (superior sulcus) tumors
    • Detterbeck FC. Pancoast (superior sulcus) tumors. Ann Thorac Surg 1997; 63:1810-1818
    • (1997) Ann Thorac Surg , vol.63 , pp. 1810-1818
    • Detterbeck, F.C.1
  • 25
    • 0021268776 scopus 로고
    • Pancoast's tumor
    • Shaw RR. Pancoast's tumor. Ann Thorac Surg 1984; 37:343-345
    • (1984) Ann Thorac Surg , vol.37 , pp. 343-345
    • Shaw, R.R.1
  • 27
    • 0025169821 scopus 로고
    • A clinical-severity staging system for patients with lung cancer
    • Feinstein AR, Wells CK. A clinical-severity staging system for patients with lung cancer. Medicine (Baltimore) 1990; 69:1-33
    • (1990) Medicine (Baltimore) , vol.69 , pp. 1-33
    • Feinstein, A.R.1    Wells, C.K.2
  • 28
    • 0030943809 scopus 로고    scopus 로고
    • A practical prognostic index for inoperable non-small-cell lung cancer
    • Wigren T, Oksanen H, Kellokumpu-Lehtinen P. A practical prognostic index for inoperable non-small-cell lung cancer. J Cancer Res Clin Oncol 1997; 123:259-266
    • (1997) J Cancer Res Clin Oncol , vol.123 , pp. 259-266
    • Wigren, T.1    Oksanen, H.2    Kellokumpu-Lehtinen, P.3
  • 29
    • 0035192929 scopus 로고    scopus 로고
    • Predictive factors in radiotherapy for non-small cell lung cancer: Present status
    • Choi N, Baumann M, Flentjie M, et al. Predictive factors in radiotherapy for non-small cell lung cancer: present status. Lung Cancer 2001; 31:43-56
    • (2001) Lung Cancer , vol.31 , pp. 43-56
    • Choi, N.1    Baumann, M.2    Flentjie, M.3
  • 30
    • 0030831308 scopus 로고    scopus 로고
    • Laminin and cathepsin B as prognostic factors in stage I non-small cell lung cancer: Are they useful?
    • Mori M, Kohli A, Baker SP, et al. Laminin and cathepsin B as prognostic factors in stage I non-small cell lung cancer: are they useful? Mod Pathol 1997; 10:572-577
    • (1997) Mod Pathol , vol.10 , pp. 572-577
    • Mori, M.1    Kohli, A.2    Baker, S.P.3
  • 31
    • 0030996171 scopus 로고    scopus 로고
    • Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma: A prospective study
    • Fontanini G, Lucchi M, Vignati S, et al. Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma: a prospective study. J Natl Cancer Inst 1997; 89:881-886
    • (1997) J Natl Cancer Inst , vol.89 , pp. 881-886
    • Fontanini, G.1    Lucchi, M.2    Vignati, S.3
  • 32
    • 0024222236 scopus 로고
    • The spectrum and significance of bronchioloalveolar carcinomas
    • Clayton F. The spectrum and significance of bronchioloalveolar carcinomas. Pathol Annu 1988; 23:361-394
    • (1988) Pathol Annu , vol.23 , pp. 361-394
    • Clayton, F.1
  • 33
    • 0030904756 scopus 로고    scopus 로고
    • Pretreatment characteristics of carcinoid tumors of the lung which predict aggressive behavior
    • Perkins P, Kemp BL, Putnam JBJ, et al. Pretreatment characteristics of carcinoid tumors of the lung which predict aggressive behavior. Am J Clin Oncol 1997; 20:285-288
    • (1997) Am J Clin Oncol , vol.20 , pp. 285-288
    • Perkins, P.1    Kemp, B.L.2    Putnam, J.B.J.3
  • 34
    • 0029911353 scopus 로고    scopus 로고
    • Carcinoid tumors of the lung: Immuno- and ligandohistochemistry, analysis of integrated optical density, syntactic structure analysis, clinical data, and prognosis of patients treated surgically
    • Kayser K, Kayser C, Rahn W, et al. Carcinoid tumors of the lung: immuno- and ligandohistochemistry, analysis of integrated optical density, syntactic structure analysis, clinical data, and prognosis of patients treated surgically. J Surg Oncol 1996; 63:99-106
    • (1996) J Surg Oncol , vol.63 , pp. 99-106
    • Kayser, K.1    Kayser, C.2    Rahn, W.3
  • 35
    • 0032959632 scopus 로고    scopus 로고
    • A biologic risk model for stage I lung cancer: Immunohistochemical analysis of 408 patients with the use of ten molecular markers
    • D'Amico TA, Massey M, Herndon JE, et al. A biologic risk model for stage I lung cancer: immunohistochemical analysis of 408 patients with the use of ten molecular markers. Thorac Cardiovasc Surg 1999; 117:736-743
    • (1999) Thorac Cardiovasc Surg , vol.117 , pp. 736-743
    • D'Amico, T.A.1    Massey, M.2    Herndon, J.E.3
  • 36
    • 0029064674 scopus 로고
    • Biologic and molecular prognostic factors: Impact on treatment of patients with non-small cell lung cancer
    • Johnson BE. Biologic and molecular prognostic factors: impact on treatment of patients with non-small cell lung cancer. Chest 1995; 107:287S-290S
    • (1995) Chest , vol.107 , pp. 287S-290S
    • Johnson, B.E.1
  • 37
    • 0029765583 scopus 로고    scopus 로고
    • Prognostic significance of germ line polymorphisms of the CYP1A1 and glutathione S-transferase genes in patients with non-small cell lung cancer
    • Goto I, Yoneda S, Yamamoto M, et al. Prognostic significance of germ line polymorphisms of the CYP1A1 and glutathione S-transferase genes in patients with non-small cell lung cancer. Cancer Res 1996; 56:3725-3730
    • (1996) Cancer Res , vol.56 , pp. 3725-3730
    • Goto, I.1    Yoneda, S.2    Yamamoto, M.3
  • 38
    • 0031764876 scopus 로고    scopus 로고
    • Further comments on "A practical prognostic index for inoperable non-small-cell lung cancer": A clinical biologist's point of view
    • Watine J. Further comments on "A practical prognostic index for inoperable non-small-cell lung cancer": a clinical biologist's point of view. J Cancer Res Clin Oncol 1998; 124:581-583
    • (1998) J Cancer Res Clin Oncol , vol.124 , pp. 581-583
    • Watine, J.1
  • 40
    • 0010588929 scopus 로고    scopus 로고
    • Deregulation of the cell cycle in lung cancer
    • Brambilla C, Brambilla E, eds. New York, NY: Marcel Dekker
    • Michalides RJ. Deregulation of the cell cycle in lung cancer. In: Brambilla C, Brambilla E, eds. Lung tumors: fundamental biology and clinical management. New York, NY: Marcel Dekker, 1999
    • (1999) Lung Tumors: Fundamental Biology and Clinical Management
    • Michalides, R.J.1
  • 41
    • 0034729357 scopus 로고    scopus 로고
    • Prognostic significance of p53 mutations in non-small cell lung cancer: A meta-analysis of 829 cases from eight published studies
    • Huncharek M, Kupelnick B, Geschwind JF, et al. Prognostic significance of p53 mutations in non-small cell lung cancer: a meta-analysis of 829 cases from eight published studies. Cancer Lett 2000; 153:219-226
    • (2000) Cancer Lett , vol.153 , pp. 219-226
    • Huncharek, M.1    Kupelnick, B.2    Geschwind, J.F.3
  • 42
    • 0033765491 scopus 로고    scopus 로고
    • Prognostic significance of p53 alterations in patients with non-small cell lung cancer: A meta-analysis
    • Mitsudomi T, Hamajima N, Ogawa M, et al. Prognostic significance of p53 alterations in patients with non-small cell lung cancer: a meta-analysis. Clin Cancer Res 2000; 6:4055-4063
    • (2000) Clin Cancer Res , vol.6 , pp. 4055-4063
    • Mitsudomi, T.1    Hamajima, N.2    Ogawa, M.3
  • 43
    • 0035816267 scopus 로고    scopus 로고
    • Aneuploidy and prognosis of non-small-cell lung cancer: A meta-analysis of published data
    • Choma D, Daures JP, Quantin X, et al. Aneuploidy and prognosis of non-small-cell lung cancer: a meta-analysis of published data. Br J Cancer 2001; 85:14-22
    • (2001) Br J Cancer , vol.85 , pp. 14-22
    • Choma, D.1    Daures, J.P.2    Quantin, X.3
  • 44
    • 0033994195 scopus 로고    scopus 로고
    • Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA
    • van Rens MT, de la Riviere AB, Elbers HR, et al. Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA. Chest 2000; 117:374-379
    • (2000) Chest , vol.117 , pp. 374-379
    • Van Rens, M.T.1    De la Riviere, A.B.2    Elbers, H.R.3
  • 46
    • 0026759013 scopus 로고
    • New aspects in the staging of lung cancer: Prospective validation of the International Union Against Cancer TNM classification
    • Bulzebruck H, Bopp R, Drings P, et al. New aspects in the staging of lung cancer: prospective validation of the International Union Against Cancer TNM classification. Cancer 1992; 70:1102-1110
    • (1992) Cancer , vol.70 , pp. 1102-1110
    • Bulzebruck, H.1    Bopp, R.2    Drings, P.3
  • 47
    • 0034035234 scopus 로고    scopus 로고
    • Prognostic value of stage grouping and TNM descriptors in lung cancer
    • Buccheri G, Ferrigno D. Prognostic value of stage grouping and TNM descriptors in lung cancer. Chest 2000; 117:1247-1255
    • (2000) Chest , vol.117 , pp. 1247-1255
    • Buccheri, G.1    Ferrigno, D.2
  • 48
    • 0034099593 scopus 로고    scopus 로고
    • Results of surgical treatment of non-small cell lung cancer: Validation of the new postoperative pathologic TNM classification
    • Jassem J, Skokowski J, Dziadziuszko R, et al. Results of surgical treatment of non-small cell lung cancer: validation of the new postoperative pathologic TNM classification. Thorac Cardiovasc Surg 2000; 119:1141-1146
    • (2000) Thorac Cardiovasc Surg , vol.119 , pp. 1141-1146
    • Jassem, J.1    Skokowski, J.2    Dziadziuszko, R.3
  • 49
    • 0033396816 scopus 로고    scopus 로고
    • Lung cancer treatment decisions: Patients' desires for participation and information
    • Davidson JR, Brundage MD, Feldman-Stewart D. Lung cancer treatment decisions: patients' desires for participation and information. Psychooncology 1999; 8:511-520
    • (1999) Psychooncology , vol.8 , pp. 511-520
    • Davidson, J.R.1    Brundage, M.D.2    Feldman-Stewart, D.3
  • 50
    • 0031748935 scopus 로고    scopus 로고
    • Using a treatment-tradeoff methods to elicit preferences for the treatment of locally advanced non-small cell lung cancer
    • Brundage MD, Davidson JR, Mackillop W, et al. Using a treatment-tradeoff methods to elicit preferences for the treatment of locally advanced non-small cell lung cancer. Med Decis Making 1998; 18:256-267
    • (1998) Med Decis Making , vol.18 , pp. 256-267
    • Brundage, M.D.1    Davidson, J.R.2    Mackillop, W.3
  • 51
    • 0026752542 scopus 로고
    • Prognostic value of the tissue polypeptide antigen in lung cancer
    • Buccheri G, Ferrigno D. Prognostic value of the tissue polypeptide antigen in lung cancer. Chest 1992; 101:1287-1292
    • (1992) Chest , vol.101 , pp. 1287-1292
    • Buccheri, G.1    Ferrigno, D.2
  • 52
    • 0029985164 scopus 로고    scopus 로고
    • Gender influence on weight-loss pattern and survival of nonsmall cell lung carcinoma patients
    • Palomares MR, Sayre JW, Shekar KC, et al. Gender influence on weight-loss pattern and survival of nonsmall cell lung carcinoma patients. Cancer 1996; 78:2119-2126
    • (1996) Cancer , vol.78 , pp. 2119-2126
    • Palomares, M.R.1    Sayre, J.W.2    Shekar, K.C.3
  • 53
    • 0026477527 scopus 로고
    • The use of discriminant analysis to guide palliative treatment for lung cancer patients
    • Thorogood J, Bulman AS, Collins T, et al. The use of discriminant analysis to guide palliative treatment for lung cancer patients. Clin Oncol (R Coll Radiol) 1992; 4:22-26
    • (1992) Clin Oncol (R Coll Radiol) , vol.4 , pp. 22-26
    • Thorogood, J.1    Bulman, A.S.2    Collins, T.3
  • 54
    • 0029819443 scopus 로고    scopus 로고
    • Tumor-induced hypercalcemia and parathyroid hormone-related protein in lung carcinoma
    • Takai E, Yano T, Iguchi H, et al. Tumor-induced hypercalcemia and parathyroid hormone-related protein in lung carcinoma. Cancer 1996; 78:1384-1387
    • (1996) Cancer , vol.78 , pp. 1384-1387
    • Takai, E.1    Yano, T.2    Iguchi, H.3
  • 55
    • 0030176378 scopus 로고    scopus 로고
    • Performance status scoring in lung cancer: A prospective, longitudinal study of 536 patients from a single institution
    • Buccheri G, Ferrigno D, Tamburini M Karnofsky, and ECOG. performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institution. Eur J Cancer 1996; 32A:1135-1141
    • (1996) Eur J Cancer , vol.32 A , pp. 1135-1141
    • Buccheri, G.1    Ferrigno, D.2    Tamburini, M.K.3
  • 56
    • 0026090161 scopus 로고
    • Pre-treatment prognostic factors in stage III non-small cell lung cancer patients receiving combined modality treatment
    • Bonomi P, Gale M, Rowland K, et al. Pre-treatment prognostic factors in stage III non-small cell lung cancer patients receiving combined modality treatment. Int J Radiat Oncol Biol Phys 1991; 20:247-252
    • (1991) Int J Radiat Oncol Biol Phys , vol.20 , pp. 247-252
    • Bonomi, P.1    Gale, M.2    Rowland, K.3
  • 57
    • 0031041775 scopus 로고    scopus 로고
    • Prognostic value of pleural effusion in patients with non-small cell lung cancer
    • Sugiura S, Ando Y, Minami H, et al. Prognostic value of pleural effusion in patients with non-small cell lung cancer. Clin Cancer Res 1997; 3:47-50
    • (1997) Clin Cancer Res , vol.3 , pp. 47-50
    • Sugiura, S.1    Ando, Y.2    Minami, H.3
  • 58
    • 0027715951 scopus 로고
    • Analysis of early and late deaths on RTOG non-small cell carcinoma of the lung trials: Comparison with CALGB 8433
    • Komaki R, Pajak TF, Byhardt RW, et al. Analysis of early and late deaths on RTOG non-small cell carcinoma of the lung trials: comparison with CALGB 8433. Lung Cancer 1993; 10:189-197
    • (1993) Lung Cancer , vol.10 , pp. 189-197
    • Komaki, R.1    Pajak, T.F.2    Byhardt, R.W.3
  • 59
    • 0032991503 scopus 로고    scopus 로고
    • Prognostic factors for short-term survival in patients with stage IV non-small cell lung cancer
    • Ando M, Ando Y, Sugiura S, et al. Prognostic factors for short-term survival in patients with stage IV non-small cell lung cancer. Jpn J Cancer Res 1999; 90:249-253
    • (1999) Jpn J Cancer Res , vol.90 , pp. 249-253
    • Ando, M.1    Ando, Y.2    Sugiura, S.3
  • 60
    • 0030739929 scopus 로고    scopus 로고
    • Confirmation of a prognostic index for patients with inoperable non-small cell lung cancer
    • Wigren T. Confirmation of a prognostic index for patients with inoperable non-small cell lung cancer. Radiother Oncol 1997; 44:9-15
    • (1997) Radiother Oncol , vol.44 , pp. 9-15
    • Wigren, T.1
  • 61
    • 0027201887 scopus 로고
    • Effect of radiologic stage III substage on nonsurgical therapy of non-small cell lung cancer
    • Kreisman H, Lisbona A, Olson L, et al. Effect of radiologic stage III substage on nonsurgical therapy of non-small cell lung cancer. Cancer 1993; 72:1588-1596
    • (1993) Cancer , vol.72 , pp. 1588-1596
    • Kreisman, H.1    Lisbona, A.2    Olson, L.3
  • 62
    • 0344628764 scopus 로고    scopus 로고
    • Trimodality therapy in stage III non-small cell lung cancer: Prediction of recurrence by assessment of p185neu
    • Thomas M, Rube C, Semik M, et al. Trimodality therapy in stage III non-small cell lung cancer: prediction of recurrence by assessment of p185neu. Eur Respir J 1999; 13:424-429
    • (1999) Eur Respir J , vol.13 , pp. 424-429
    • Thomas, M.1    Rube, C.2    Semik, M.3
  • 63
    • 0031409715 scopus 로고    scopus 로고
    • Pleural effusion as a significant prognostic factor in non-small cell lung cancer
    • Naito T, Satoh H, Ishikawa H, et al. Pleural effusion as a significant prognostic factor in non-small cell lung cancer. Anticancer Res 1997; 17:4743-4746
    • (1997) Anticancer Res , vol.17 , pp. 4743-4746
    • Naito, T.1    Satoh, H.2    Ishikawa, H.3
  • 64
    • 0027313590 scopus 로고
    • Prognostic factors in lung cancer based on multivariate analysis
    • Hilsenbeck SG, Raub WAJ, Sridhar KS. Prognostic factors in lung cancer based on multivariate analysis. Am J Clin Oncol 1993; 16:301-309
    • (1993) Am J Clin Oncol , vol.16 , pp. 301-309
    • Hilsenbeck, S.G.1    Raub, W.A.J.2    Sridhar, K.S.3
  • 65
    • 0031030245 scopus 로고    scopus 로고
    • Haemostatic abnormalities in lung cancer: Prognostic implications
    • Buccheri G, Ferrigno D, Ginardi C, et al. Haemostatic abnormalities in lung cancer: prognostic implications. Eur J Cancer 1997; 33:50-55
    • (1997) Eur J Cancer , vol.33 , pp. 50-55
    • Buccheri, G.1    Ferrigno, D.2    Ginardi, C.3
  • 66
    • 9844224493 scopus 로고    scopus 로고
    • Long-term survivors of small-cell lung cancer (SCLC): A French multicenter study
    • Groupe d'Oncologie de Langue Francaise
    • Jacoulet P, Depierre A, Moro D, et al. Long-term survivors of small-cell lung cancer (SCLC): a French multicenter study; Groupe d'Oncologie de Langue Francaise. Ann Oncol 1997; 8:1009-1014
    • (1997) Ann Oncol , vol.8 , pp. 1009-1014
    • Jacoulet, P.1    Depierre, A.2    Moro, D.3
  • 67
    • 0030754024 scopus 로고    scopus 로고
    • Prognostic significance of plasma D-dimer levels in patients with lung cancer
    • Taguchi O, Gabazza EC, Yasui H, et al. Prognostic significance of plasma D-dimer levels in patients with lung cancer. Thorax 1997; 52:563-565
    • (1997) Thorax , vol.52 , pp. 563-565
    • Taguchi, O.1    Gabazza, E.C.2    Yasui, H.3
  • 68
    • 0026688455 scopus 로고
    • Prognostic significance of blood coagulation tests in carcinoma of the lung and colon
    • Wojtukiewicz MZ, Zacharski LR, Moritz TE, et al. Prognostic significance of blood coagulation tests in carcinoma of the lung and colon. Blood Coagul Fibrinolysis 1992; 3:429-437
    • (1992) Blood Coagul Fibrinolysis , vol.3 , pp. 429-437
    • Wojtukiewicz, M.Z.1    Zacharski, L.R.2    Moritz, T.E.3
  • 69
    • 10344231430 scopus 로고    scopus 로고
    • Prevalence and prognostic significance of proteinuria in patients with lung cancer
    • Pedersen LM, Milman N. Prevalence and prognostic significance of proteinuria in patients with lung cancer. Acta Oncol 1996; 35:691-695
    • (1996) Acta Oncol , vol.35 , pp. 691-695
    • Pedersen, L.M.1    Milman, N.2
  • 70
    • 0031892681 scopus 로고    scopus 로고
    • Depressive reactions to lung cancer are common and often followed by a poor outcome
    • Buccheri G. Depressive reactions to lung cancer are common and often followed by a poor outcome. Eur Respir J 1998; 11:173-178
    • (1998) Eur Respir J , vol.11 , pp. 173-178
    • Buccheri, G.1
  • 71
    • 0026325903 scopus 로고
    • Prognostic value of nuclear DNA content and expression of the ras oncogene product in lung cancer
    • Miyamoto H, Harada M, Isobe H, et al. Prognostic value of nuclear DNA content and expression of the ras oncogene product in lung cancer. Cancer Res 1991; 51:6346-6350
    • (1991) Cancer Res , vol.51 , pp. 6346-6350
    • Miyamoto, H.1    Harada, M.2    Isobe, H.3
  • 72
    • 0027440644 scopus 로고
    • Prognostic significance of the proliferation index in surgically resected non-small-cell lung cancer
    • Pence JC, Kerns BJ, Dodge RK, et al. Prognostic significance of the proliferation index in surgically resected non-small-cell lung cancer. Arch Surg 1993; 128:1382-1390
    • (1993) Arch Surg , vol.128 , pp. 1382-1390
    • Pence, J.C.1    Kerns, B.J.2    Dodge, R.K.3
  • 73
    • 8044256501 scopus 로고    scopus 로고
    • Prognostic value of replication errors on chromosomes 2p and 3p in non-small-cell lung cancer
    • Pifarre A, Rosell R, Monzo M, et al. Prognostic value of replication errors on chromosomes 2p and 3p in non-small-cell lung cancer. Br J Cancer 1997; 75:184-189
    • (1997) Br J Cancer , vol.75 , pp. 184-189
    • Pifarre, A.1    Rosell, R.2    Monzo, M.3
  • 74
    • 0030760737 scopus 로고    scopus 로고
    • The utility of p53 immunostaining of transbronchial biopsy specimens of lung cancer: p53 overexpression predicts poor prognosis and chemoresistance in advanced non-small cell lung cancer
    • Kawasaki M, Nakanishi Y, Kuwano K, et al. The utility of p53 immunostaining of transbronchial biopsy specimens of lung cancer: p53 overexpression predicts poor prognosis and chemoresistance in advanced non-small cell lung cancer. Clin Cancer Res 1997; 3:1195-1200
    • (1997) Clin Cancer Res , vol.3 , pp. 1195-1200
    • Kawasaki, M.1    Nakanishi, Y.2    Kuwano, K.3
  • 75
    • 0027300513 scopus 로고
    • Prognostic significance of the expression of c-fos, c-jun and c-erbB-1 oncogene products in human squamous cell lung carcinomas
    • Volm M, Drings P, Wodrich W. Prognostic significance of the expression of c-fos, c-jun and c-erbB-1 oncogene products in human squamous cell lung carcinomas. J Cancer Res Clin Oncol 1993; 119:507-510
    • (1993) J Cancer Res Clin Oncol , vol.119 , pp. 507-510
    • Volm, M.1    Drings, P.2    Wodrich, W.3
  • 76
    • 0027380337 scopus 로고
    • Carcinoembryonic antigen (CEA), tissue polypeptide antigen (TPA) and other prognostic indicators in squamous cell lung cancer
    • Buccheri G, Ferrigno D, Vola F. Carcinoembryonic antigen (CEA), tissue polypeptide antigen (TPA) and other prognostic indicators in squamous cell lung cancer. Lung Cancer 1993; 10:21-33
    • (1993) Lung Cancer , vol.10 , pp. 21-33
    • Buccheri, G.1    Ferrigno, D.2    Vola, F.3
  • 77
    • 0027724642 scopus 로고
    • Neuroendocrine differentiation as a prognostic factor in non-small cell lung cancer
    • Carles J, Rosell R, Ariza A, et al. Neuroendocrine differentiation as a prognostic factor in non-small cell lung cancer. Lung Cancer 1993; 10:209-219
    • (1993) Lung Cancer , vol.10 , pp. 209-219
    • Carles, J.1    Rosell, R.2    Ariza, A.3
  • 78
    • 0027477568 scopus 로고
    • Value of serum neuron-specific enolase in nonsmall cell lung cancer
    • Diez M, Torres A, Ortega L, et al. Value of serum neuron-specific enolase in nonsmall cell lung cancer. Oncology (Huntingt) 1993; 50:127-131
    • (1993) Oncology (Huntingt) , vol.50 , pp. 127-131
    • Diez, M.1    Torres, A.2    Ortega, L.3
  • 79
    • 0030930520 scopus 로고    scopus 로고
    • Thallium-201 single photon emission computed tomography as an indicator of prognosis for patients with lung carcinoma
    • Takekawa H, Takaoka K, Tsukamoto E, et al. Thallium-201 single photon emission computed tomography as an indicator of prognosis for patients with lung carcinoma. Cancer 1997; 80:198-203
    • (1997) Cancer , vol.80 , pp. 198-203
    • Takekawa, H.1    Takaoka, K.2    Tsukamoto, E.3
  • 80
    • 0026340550 scopus 로고
    • Classification of lung cancer: First experiences with the new TNM classification (4th edition)
    • Bulzebruck H, Drings P, Kayser K, et al. Classification of lung cancer: first experiences with the new TNM classification (4th edition). Eur Respir J 1991; 4:1197-1206
    • (1991) Eur Respir J , vol.4 , pp. 1197-1206
    • Bulzebruck, H.1    Drings, P.2    Kayser, K.3
  • 81
    • 0030926263 scopus 로고    scopus 로고
    • Regional lymph node classification for lung cancer staging
    • Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest 1997; 111:1718-1723
    • (1997) Chest , vol.111 , pp. 1718-1723
    • Mountain, C.F.1    Dresler, C.M.2
  • 82
    • 0027729625 scopus 로고
    • Analysis of prognostic factors in patients with resected peripheral T1 adenocarcinoma of the lung
    • Lima C, Matsui K, Kitagawa M, et al. Analysis of prognostic factors in patients with resected peripheral T1 adenocarcinoma of the lung. Pathol Res Pract 1993; 189:1149-1153
    • (1993) Pathol Res Pract , vol.189 , pp. 1149-1153
    • Lima, C.1    Matsui, K.2    Kitagawa, M.3
  • 83
    • 0027604891 scopus 로고
    • Results of surgical treatment of stage I lung cancer
    • Shimizu J, Watanabe Y, Oda M, et al. Results of surgical treatment of stage I lung cancer. Nippon Geka Gakkai Zasshi 1993; 94:505-510
    • (1993) Nippon Geka Gakkai Zasshi , vol.94 , pp. 505-510
    • Shimizu, J.1    Watanabe, Y.2    Oda, M.3
  • 84
    • 0028966055 scopus 로고
    • A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression
    • Harpole DHJ, Herndon JE, Wolfe WG, et al. A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression. Cancer Res 1995; 55:51-56
    • (1995) Cancer Res , vol.55 , pp. 51-56
    • Harpole, D.H.J.1    Herndon, J.E.2    Wolfe, W.G.3
  • 85
    • 0028811996 scopus 로고
    • Incidence of local recurrence and second primary tumors in resected stage I lung cancer
    • Martini N, Bains MS, Burt ME, et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. Thorac Cardiovasc Surg 1995; 109:120-129
    • (1995) Thorac Cardiovasc Surg , vol.109 , pp. 120-129
    • Martini, N.1    Bains, M.S.2    Burt, M.E.3
  • 86
    • 0033557596 scopus 로고    scopus 로고
    • Five-year survivors with resected pN2 nonsmall cell lung carcinoma
    • Sagawa M, Sakurada A, Fujimura S, et al. Five-year survivors with resected pN2 nonsmall cell lung carcinoma. Cancer 1999; 85:864-868
    • (1999) Cancer , vol.85 , pp. 864-868
    • Sagawa, M.1    Sakurada, A.2    Fujimura, S.3
  • 87
    • 0031137302 scopus 로고    scopus 로고
    • Survival and prognostic factors in resected N2 non-small cell lung cancer: A study of 140 cases: Leuven Lung Cancer Group
    • Vansteenkiste JF, De Leyn PR, Deneffe GJ, et al. Survival and prognostic factors in resected N2 non-small cell lung cancer: a study of 140 cases: Leuven Lung Cancer Group. Ann Thorac Surg 1997; 63:1441-1450
    • (1997) Ann Thorac Surg , vol.63 , pp. 1441-1450
    • Vansteenkiste, J.F.1    De Leyn, P.R.2    Deneffe, G.J.3
  • 88
    • 0031883133 scopus 로고    scopus 로고
    • "Incomplete resection" in non-small cell lung cancer: Need for a new definition
    • Canadian Lung Oncology Group
    • Lacasse Y, Bucher HC, Wong E, et al. "Incomplete resection" in non-small cell lung cancer: need for a new definition; Canadian Lung Oncology Group. Ann Thorac Surg 1998; 65:220-226
    • (1998) Ann Thorac Surg , vol.65 , pp. 220-226
    • Lacasse, Y.1    Bucher, H.C.2    Wong, E.3
  • 89
    • 0030694187 scopus 로고    scopus 로고
    • Relationship between vascularity, age and survival in non-small-cell lung cancer
    • Chandrachud LM, Pendleton N, Chisholm DM, et al. Relationship between vascularity, age and survival in non-small-cell lung cancer. Br J Cancer 1997; 76:1367-1375
    • (1997) Br J Cancer , vol.76 , pp. 1367-1375
    • Chandrachud, L.M.1    Pendleton, N.2    Chisholm, D.M.3
  • 90
    • 0030036146 scopus 로고    scopus 로고
    • "Tumour volume" as a predictor of survival after resection of non-small-cell lung cancer (NSCLC)
    • Jefferson MF, Pendleton N, Faragher EB, et al. "Tumour volume" as a predictor of survival after resection of non-small-cell lung cancer (NSCLC). Br J Cancer 1996; 74:456-459
    • (1996) Br J Cancer , vol.74 , pp. 456-459
    • Jefferson, M.F.1    Pendleton, N.2    Faragher, E.B.3
  • 91
    • 0026727298 scopus 로고
    • Lung cancer in young adults
    • Bourke W, Milstein D, Giura R, et al. Lung cancer in young adults. Chest 1992; 102:1723-1729
    • (1992) Chest , vol.102 , pp. 1723-1729
    • Bourke, W.1    Milstein, D.2    Giura, R.3
  • 92
    • 0029986344 scopus 로고    scopus 로고
    • Bronchogenic cancer in the elderly: Operative risk and long-term prognosis
    • Massard G, Moog R, Wihlm JM, et al. Bronchogenic cancer in the elderly: operative risk and long-term prognosis. Thorac Cardiovasc Surg 1996; 44:40-45
    • (1996) Thorac Cardiovasc Surg , vol.44 , pp. 40-45
    • Massard, G.1    Moog, R.2    Wihlm, J.M.3
  • 93
    • 0027248096 scopus 로고
    • Prognostic significance of metastases to mediastinal lymph node levels in resected non-small cell lung carcinoma
    • Conill C, Astudillo J, Verger E. Prognostic significance of metastases to mediastinal lymph node levels in resected non-small cell lung carcinoma. Cancer 1993; 72:1199-1202
    • (1993) Cancer , vol.72 , pp. 1199-1202
    • Conill, C.1    Astudillo, J.2    Verger, E.3
  • 94
    • 0027762049 scopus 로고
    • Prognostic significance of pleural lavage cytology immediately after thoracotomy in patients with lung cancer
    • Kondo H, Asamura H, Suemasu K, et al. Prognostic significance of pleural lavage cytology immediately after thoracotomy in patients with lung cancer. Thorac Cardiovasc Surg 1993; 106:1092-1097
    • (1993) Thorac Cardiovasc Surg , vol.106 , pp. 1092-1097
    • Kondo, H.1    Asamura, H.2    Suemasu, K.3
  • 95
    • 0030951621 scopus 로고    scopus 로고
    • The prognostic significance of tumor cell detection in intraoperative pleural lavage and lung tissue cultures for patients with lung cancer
    • Buhr J, Berghauser KH, Gonner S, et al. The prognostic significance of tumor cell detection in intraoperative pleural lavage and lung tissue cultures for patients with lung cancer. Thorac Cardiovasc Surg 1997; 113:683-690
    • (1997) Thorac Cardiovasc Surg , vol.113 , pp. 683-690
    • Buhr, J.1    Berghauser, K.H.2    Gonner, S.3
  • 96
    • 0030865353 scopus 로고    scopus 로고
    • Prognosis of ipsilateral intrapulmonary metastases in resected nonsmall cell lung cancer
    • Fukuse T, Hirata T, Tanaka F, et al. Prognosis of ipsilateral intrapulmonary metastases in resected nonsmall cell lung cancer. Eur J Cardiothorac Surg 1997; 12:218-223
    • (1997) Eur J Cardiothorac Surg , vol.12 , pp. 218-223
    • Fukuse, T.1    Hirata, T.2    Tanaka, F.3
  • 97
    • 0027301691 scopus 로고
    • Is T factor of the TNM staging system a predominant prognostic factor in pathologic stage I non-small-cell lung cancer? A multivariate prognostic factor analysis of 151 patients
    • Ichinose Y, Hara N, Ohta M, et al. Is T factor of the TNM staging system a predominant prognostic factor in pathologic stage I non-small-cell lung cancer? A multivariate prognostic factor analysis of 151 patients. Thorac Cardiovasc Surg 1993; 106:90-94
    • (1993) Thorac Cardiovasc Surg , vol.106 , pp. 90-94
    • Ichinose, Y.1    Hara, N.2    Ohta, M.3
  • 98
    • 0026029716 scopus 로고
    • Prognostic factors for surgically treated lung adenocarcinoma patients, with special reference to smoking habit
    • Sobue T, Suzuki T, Fujimoto I, et al. Prognostic factors for surgically treated lung adenocarcinoma patients, with special reference to smoking habit. Jpn J Cancer Res 1991; 82:33-39
    • (1991) Jpn J Cancer Res , vol.82 , pp. 33-39
    • Sobue, T.1    Suzuki, T.2    Fujimoto, I.3
  • 99
    • 0032411362 scopus 로고    scopus 로고
    • Results after surgery in stage-I bronchogenic carcinoma
    • Wertzel H, Siebert H, Lange W, et al. Results after surgery in stage-I bronchogenic carcinoma. Thorac Cardiovasc Surg 1998; 46:365-369
    • (1998) Thorac Cardiovasc Surg , vol.46 , pp. 365-369
    • Wertzel, H.1    Siebert, H.2    Lange, W.3
  • 100
    • 9344265211 scopus 로고    scopus 로고
    • Prediction of survival and recurrence by serum and cytosolic levels of CEA, CA125 and SCC antigens in resectable non-small-cell lung cancer
    • Diez M, Torres A, Maestro ML, et al. Prediction of survival and recurrence by serum and cytosolic levels of CEA, CA125 and SCC antigens in resectable non-small-cell lung cancer. Br J Cancer 1996; 73:1248-1254
    • (1996) Br J Cancer , vol.73 , pp. 1248-1254
    • Diez, M.1    Torres, A.2    Maestro, M.L.3
  • 101
    • 0021231694 scopus 로고
    • Prognostic factors in patients with resected stage I non-small cell lung cancer: A report from the Lung Cancer Study Group
    • Gail MH, Eagan RT, Feld R, et al. Prognostic factors in patients with resected stage I non-small cell lung cancer: a report from the Lung Cancer Study Group. Cancer 1984; 54:1802-1813
    • (1984) Cancer , vol.54 , pp. 1802-1813
    • Gail, M.H.1    Eagan, R.T.2    Feld, R.3
  • 102
    • 0022410638 scopus 로고
    • The role of serum tumour markers to aid the selection of lung cancer patients for surgery and the assessment of prognosis
    • Muller T, Marshall RJ, Cooper EH, et al. The role of serum tumour markers to aid the selection of lung cancer patients for surgery and the assessment of prognosis. Eur J Cancer Clin Oncol 1985; 21:1461-1466
    • (1985) Eur J Cancer Clin Oncol , vol.21 , pp. 1461-1466
    • Muller, T.1    Marshall, R.J.2    Cooper, E.H.3
  • 103
    • 0021266417 scopus 로고
    • Bronchial carcinoma: Factors influencing postoperative survival
    • Clee MD, Hockings NF, Johnston RN. Bronchial carcinoma: factors influencing postoperative survival. Br J Dis Chest 1984; 78:225-235
    • (1984) Br J Dis Chest , vol.78 , pp. 225-235
    • Clee, M.D.1    Hockings, N.F.2    Johnston, R.N.3
  • 104
    • 0027326034 scopus 로고
    • Blood vessel invasion by tumor cells predicts recurrence in completely resected T1 N0 M0 non-small-cell lung cancer
    • Macchiarini P, Fontanini G, Hardin MJ, et al. Blood vessel invasion by tumor cells predicts recurrence in completely resected T1 N0 M0 non-small-cell lung cancer. Thorac Cardiovasc Surg 1993; 106:80-89
    • (1993) Thorac Cardiovasc Surg , vol.106 , pp. 80-89
    • Macchiarini, P.1    Fontanini, G.2    Hardin, M.J.3
  • 105
    • 0029910834 scopus 로고    scopus 로고
    • Blood vessel and lymphatic vessel invasion in resected nonsmall cell lung carcinoma: Correlation with TNM stage and disease free and overall survival
    • Brechot JM, Chevret S, Charpentier MC, et al. Blood vessel and lymphatic vessel invasion in resected nonsmall cell lung carcinoma: correlation with TNM stage and disease free and overall survival. Cancer 1996; 78:2111-2118
    • (1996) Cancer , vol.78 , pp. 2111-2118
    • Brechot, J.M.1    Chevret, S.2    Charpentier, M.C.3
  • 106
    • 0030296793 scopus 로고    scopus 로고
    • Blood vessel invasion is a major prognostic factor in resected non-small cell lung cancer
    • Kessler R, Gasser B, Massard G, et al. Blood vessel invasion is a major prognostic factor in resected non-small cell lung cancer. Ann Thorac Surg 1996; 62:1489-1493
    • (1996) Ann Thorac Surg , vol.62 , pp. 1489-1493
    • Kessler, R.1    Gasser, B.2    Massard, G.3
  • 107
    • 0031899930 scopus 로고    scopus 로고
    • Prognostic biomarker study in pathologically staged N1 non-small cell lung cancer
    • Komaki R, Milas L, Ro JY, et al. Prognostic biomarker study in pathologically staged N1 non-small cell lung cancer. Int J Radiat Oncol Biol Phys 1998; 40:787-796
    • (1998) Int J Radiat Oncol Biol Phys , vol.40 , pp. 787-796
    • Komaki, R.1    Milas, L.2    Ro, J.Y.3
  • 108
    • 0030271689 scopus 로고    scopus 로고
    • Apoptosis and mitosis as prognostic factors in pathologically staged N1 nonsmall cell lung cancer
    • Komaki R, Fujii T, Perkins P, et al. Apoptosis and mitosis as prognostic factors in pathologically staged N1 nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys 1996; 36:601-605
    • (1996) Int J Radiat Oncol Biol Phys , vol.36 , pp. 601-605
    • Komaki, R.1    Fujii, T.2    Perkins, P.3
  • 109
    • 0031945469 scopus 로고    scopus 로고
    • Angiogenesis as a predictor of survival after surgical resection for stage I non-small-cell lung cancer
    • Duarte IG, Bufkin BL, Pennington MF, et al. Angiogenesis as a predictor of survival after surgical resection for stage I non-small-cell lung cancer. Thorac Cardiovasc Surg 1998; 115:652-658
    • (1998) Thorac Cardiovasc Surg , vol.115 , pp. 652-658
    • Duarte, I.G.1    Bufkin, B.L.2    Pennington, M.F.3
  • 110
    • 0030668890 scopus 로고    scopus 로고
    • Tumor angiogenesis and biologic markers in resected stage I NSCLC
    • Lucchi M, Fontanini G, Mussi A, et al. Tumor angiogenesis and biologic markers in resected stage I NSCLC. Eur J Cardiothorac Surg 1997; 12:535-541
    • (1997) Eur J Cardiothorac Surg , vol.12 , pp. 535-541
    • Lucchi, M.1    Fontanini, G.2    Mussi, A.3
  • 111
    • 0029933365 scopus 로고    scopus 로고
    • A palliative accelerated irradiation regimen (PAIR) for advanced non-small-cell lung cancer (NSCLC)
    • Nestle U, Nieder C, Abel U, et al. A palliative accelerated irradiation regimen (PAIR) for advanced non-small-cell lung cancer (NSCLC). Radiother Oncol 1996; 38:195-203
    • (1996) Radiother Oncol , vol.38 , pp. 195-203
    • Nestle, U.1    Nieder, C.2    Abel, U.3
  • 112
    • 0029891577 scopus 로고    scopus 로고
    • Recurrence and death in non-small cell lung carcinomas: A prognostic model using pathological parameters, microvessel count, and gene protein products
    • Fontanini G, Vignati S, Bigini D, et al. Recurrence and death in non-small cell lung carcinomas: a prognostic model using pathological parameters, microvessel count, and gene protein products. Clin Cancer Res 1996; 2:1067-1075
    • (1996) Clin Cancer Res , vol.2 , pp. 1067-1075
    • Fontanini, G.1    Vignati, S.2    Bigini, D.3
  • 113
    • 0031907022 scopus 로고    scopus 로고
    • Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: Amphiregulin and microvessel count are independent prognostic indicators of survival
    • Fontanini G, De Laurentiis M, Vignati S, et al. Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: amphiregulin and microvessel count are independent prognostic indicators of survival. Clin Cancer Res 1998; 4:241-249
    • (1998) Clin Cancer Res , vol.4 , pp. 241-249
    • Fontanini, G.1    De Laurentiis, M.2    Vignati, S.3
  • 114
    • 8244233169 scopus 로고    scopus 로고
    • Neoangiogenesis and p53 protein in lung cancer: Their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression
    • Fontanini G, Vignati S, Lucchi M, et al. Neoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression. Br J Cancer 1997; 75:1295-1301
    • (1997) Br J Cancer , vol.75 , pp. 1295-1301
    • Fontanini, G.1    Vignati, S.2    Lucchi, M.3
  • 115
    • 0031398777 scopus 로고    scopus 로고
    • Tumor angiogenesis in pulmonary adenocarcinomas: Relationship with basic fibroblast growth factor, its receptor, and survival
    • Takanami I, Tanaka F, Hashizume T, et al. Tumor angiogenesis in pulmonary adenocarcinomas: relationship with basic fibroblast growth factor, its receptor, and survival. Neoplasma 1997; 44:295-298
    • (1997) Neoplasma , vol.44 , pp. 295-298
    • Takanami, I.1    Tanaka, F.2    Hashizume, T.3
  • 116
    • 0024530868 scopus 로고
    • Morphometric and morphologic evaluations in stage III non-small cell lung cancers: Prognostic significance of quantitative assessment of infiltrating lymphoid cells
    • Lee TK, Horner RD, Silverman JF, et al. Morphometric and morphologic evaluations in stage III non-small cell lung cancers: prognostic significance of quantitative assessment of infiltrating lymphoid cells. Cancer 1989; 63:309-316
    • (1989) Cancer , vol.63 , pp. 309-316
    • Lee, T.K.1    Horner, R.D.2    Silverman, J.F.3
  • 117
    • 0025810303 scopus 로고
    • Expression of blood-group antigen A: A favorable prognostic factor in non-small-cell lung cancer
    • Lee JS, Ro JY, Sahin AA, et al. Expression of blood-group antigen A: a favorable prognostic factor in non-small-cell lung cancer. N Engl J Med 1991; 324:1084-1090
    • (1991) N Engl J Med , vol.324 , pp. 1084-1090
    • Lee, J.S.1    Ro, J.Y.2    Sahin, A.A.3
  • 118
    • 0026734888 scopus 로고
    • Correlation of expression of H/Le(y)/Le(b) antigens with survival in patients with carcinoma of the lung
    • Miyake M, Taki T, Hitomi S, et al. Correlation of expression of H/Le(y)/Le(b) antigens with survival in patients with carcinoma of the lung. N Engl J Med 1992; 327:14-18
    • (1992) N Engl J Med , vol.327 , pp. 14-18
    • Miyake, M.1    Taki, T.2    Hitomi, S.3
  • 119
    • 0032433708 scopus 로고    scopus 로고
    • Lewis Y antigen expression and postoperative survival in non-small cell lung cancer
    • Tanaka F, Miyahara R, Ohtake Y, et al. Lewis Y antigen expression and postoperative survival in non-small cell lung cancer. Ann Thorac Surg 1998; 66:1745-1750
    • (1998) Ann Thorac Surg , vol.66 , pp. 1745-1750
    • Tanaka, F.1    Miyahara, R.2    Ohtake, Y.3
  • 120
    • 0031979703 scopus 로고    scopus 로고
    • Do molecular markers predict survival in non-small-cell lung cancer?
    • Greatens TM, Niehans GA, Rubins JB, et al. Do molecular markers predict survival in non-small-cell lung cancer? Am J Respir Crit Care Med 1998; 157:1093-1097
    • (1998) Am J Respir Crit Care Med , vol.157 , pp. 1093-1097
    • Greatens, T.M.1    Niehans, G.A.2    Rubins, J.B.3
  • 121
    • 0026019680 scopus 로고
    • Occurrence of neuron specific enolase in tumour tissue and serum in small cell lung cancer
    • Jorgensen LG, Hirsch FR, Skov BG, et al. Occurrence of neuron specific enolase in tumour tissue and serum in small cell lung cancer. Br J Cancer 1991; 63:151-153
    • (1991) Br J Cancer , vol.63 , pp. 151-153
    • Jorgensen, L.G.1    Hirsch, F.R.2    Skov, B.G.3
  • 122
    • 0029865287 scopus 로고    scopus 로고
    • Combined modality therapy of lung cancer and lung tolerance
    • Abratt RP. Combined modality therapy of lung cancer and lung tolerance. J Clin Oncol 1996; 14:1402-1403
    • (1996) J Clin Oncol , vol.14 , pp. 1402-1403
    • Abratt, R.P.1
  • 123
    • 0023225827 scopus 로고
    • Use of carcinoembryonic antigen in small cell lung cancer: Prognostic value and relation to the clinical course 1
    • Laberge F, Fritsche HA, Umsawasdi T, et al. Use of carcinoembryonic antigen in small cell lung cancer: prognostic value and relation to the clinical course 1. Cancer 1987; 59:2047-2052
    • (1987) Cancer , vol.59 , pp. 2047-2052
    • Laberge, F.1    Fritsche, H.A.2    Umsawasdi, T.3
  • 124
    • 0021934125 scopus 로고
    • Carcinoembryonic antigen: A useful prognostic marker in small-cell lung cancer
    • Sculier JP, Feld R, Evans WK, et al. Carcinoembryonic antigen: a useful prognostic marker in small-cell lung cancer. J Clin Oncol 1985; 3:1349-1354
    • (1985) J Clin Oncol , vol.3 , pp. 1349-1354
    • Sculier, J.P.1    Feld, R.2    Evans, W.K.3
  • 125
    • 0026623488 scopus 로고
    • Prognostic significance of tumor deoxyribonucleic acid content in surgically resected small-cell carcinoma of lung
    • Carey FA, Prasad US, Walker WS, et al. Prognostic significance of tumor deoxyribonucleic acid content in surgically resected small-cell carcinoma of lung. Thorac Cardiovasc Surg 1992; 103:1214-1217
    • (1992) Thorac Cardiovasc Surg , vol.103 , pp. 1214-1217
    • Carey, F.A.1    Prasad, U.S.2    Walker, W.S.3
  • 126
    • 0026010940 scopus 로고
    • Postoperative adjuvant chemotherapy in non-small cell lung cancer: Prognostic value of DNA ploidy and post-recurrent survival
    • Ichinose Y, Hara N, Ohta M, et al. Postoperative adjuvant chemotherapy in non-small cell lung cancer: prognostic value of DNA ploidy and post-recurrent survival. J Surg Oncol 1991; 46:15-20
    • (1991) J Surg Oncol , vol.46 , pp. 15-20
    • Ichinose, Y.1    Hara, N.2    Ohta, M.3
  • 127
    • 0023190493 scopus 로고
    • Ploidy as a prognostic determinant in surgically treated lung cancer
    • Zimmerman PV, Hawson GA, Bint MH, et al. Ploidy as a prognostic determinant in surgically treated lung cancer. Lancet 1987; 2:530-533
    • (1987) Lancet , vol.2 , pp. 530-533
    • Zimmerman, P.V.1    Hawson, G.A.2    Bint, M.H.3
  • 128
    • 0024435630 scopus 로고
    • DNA flow cytometric studies of 66 human lung tumors analyzed before treatment: Prognostic implications
    • Salvati F, Teodori L, Gagliardi L, et al. DNA flow cytometric studies of 66 human lung tumors analyzed before treatment: prognostic implications. Chest 1989; 96:1092-1098
    • (1989) Chest , vol.96 , pp. 1092-1098
    • Salvati, F.1    Teodori, L.2    Gagliardi, L.3
  • 129
    • 0025340655 scopus 로고
    • DNA analysis by flow cytometry in nonsmall cell lung cancer: Relationship to epidermal growth factor receptor, histology, tumour stage and survival
    • Dazzi H, Thatcher N, Hasleton PS, et al. DNA analysis by flow cytometry in nonsmall cell lung cancer: relationship to epidermal growth factor receptor, histology, tumour stage and survival. Respir Med 1990; 84:217-223
    • (1990) Respir Med , vol.84 , pp. 217-223
    • Dazzi, H.1    Thatcher, N.2    Hasleton, P.S.3
  • 130
    • 0027291490 scopus 로고
    • Prognostic significance of flow cytometry in non-small-cell lung cancer
    • Rice TW, Bauer TW, Gephardt GN, et al. Prognostic significance of flow cytometry in non-small-cell lung cancer. Thorac Cardiovasc Surg 1993; 106:210-217
    • (1993) Thorac Cardiovasc Surg , vol.106 , pp. 210-217
    • Rice, T.W.1    Bauer, T.W.2    Gephardt, G.N.3
  • 131
    • 0023931379 scopus 로고
    • Flow cytometric analysis of DNA ploidy level in paraffin-embedded tissue of non-small-cell lung cancer
    • Ten Velde GP, Schutte B, Vermeulen A, et al. Flow cytometric analysis of DNA ploidy level in paraffin-embedded tissue of non-small-cell lung cancer. Eur J Cancer Clin Oncol 1988; 24:455-460
    • (1988) Eur J Cancer Clin Oncol , vol.24 , pp. 455-460
    • Ten Velde, G.P.1    Schutte, B.2    Vermeulen, A.3
  • 132
    • 0024604666 scopus 로고
    • The effect of tumor size and tumor cell DNA content on the survival of patients with stage I adenocarcinoma of the lung
    • Cibas ES, Melamed MR, Zaman MB, et al. The effect of tumor size and tumor cell DNA content on the survival of patients with stage I adenocarcinoma of the lung. Cancer 1989; 63:1552-1556
    • (1989) Cancer , vol.63 , pp. 1552-1556
    • Cibas, E.S.1    Melamed, M.R.2    Zaman, M.B.3
  • 133
    • 0026611711 scopus 로고
    • DNA content in correlation with postsurgical stage in non-small cell lung cancer
    • Carp NZ, Ellison DD, Brophy PF, et al. DNA content in correlation with postsurgical stage in non-small cell lung cancer. Ann Thorac Surg 1992; 53:680-683
    • (1992) Ann Thorac Surg , vol.53 , pp. 680-683
    • Carp, N.Z.1    Ellison, D.D.2    Brophy, P.F.3
  • 134
    • 0025633335 scopus 로고
    • Flow cytometric analysis of tumour DNA profile related to response to radiotherapy and survival in inoperable lung cancer
    • Ojala A, Kallioniemi OP, Wigren T, et al. Flow cytometric analysis of tumour DNA profile related to response to radiotherapy and survival in inoperable lung cancer. Acta Oncol 1990; 29:983-988
    • (1990) Acta Oncol , vol.29 , pp. 983-988
    • Ojala, A.1    Kallioniemi, O.P.2    Wigren, T.3
  • 135
    • 0021924927 scopus 로고
    • Prognostic significance of DNA patterns and resistance-predictive tests in non-small cell lung carcinoma
    • Volm M, Drings P, Mattern J, et al. Prognostic significance of DNA patterns and resistance-predictive tests in non-small cell lung carcinoma. Cancer 1985; 56:1396-1403
    • (1985) Cancer , vol.56 , pp. 1396-1403
    • Volm, M.1    Drings, P.2    Mattern, J.3
  • 136
    • 0026601682 scopus 로고
    • A flow cytometric study of non-small cell lung cancer classified as T1N0
    • Schmidt RA, Rusch VW, Piantadosi S. A flow cytometric study of non-small cell lung cancer classified as T1N0. Cancer 1992; 69:78-85
    • (1992) Cancer , vol.69 , pp. 78-85
    • Schmidt, R.A.1    Rusch, V.W.2    Piantadosi, S.3
  • 137
    • 1842377483 scopus 로고    scopus 로고
    • Prognostic value of flow cytometric DNA analysis in non-small-cell lung cancer: Rationale of sequential processing of frozen and paraffin-embedded tissue
    • Muguerza JM, Diez M, Torres AJ, et al. Prognostic value of flow cytometric DNA analysis in non-small-cell lung cancer: rationale of sequential processing of frozen and paraffin-embedded tissue. World J Surg 1997; 21:323-329
    • (1997) World J Surg , vol.21 , pp. 323-329
    • Muguerza, J.M.1    Diez, M.2    Torres, A.J.3
  • 138
    • 0030925368 scopus 로고    scopus 로고
    • Clinical and flow cytometric prognostic factors in surgically treated squamous cell lung cancer
    • Kolodziejski L, Niezabitowski A, Gasinska A. Clinical and flow cytometric prognostic factors in surgically treated squamous cell lung cancer. Lung Cancer 1997; 16:173-182
    • (1997) Lung Cancer , vol.16 , pp. 173-182
    • Kolodziejski, L.1    Niezabitowski, A.2    Gasinska, A.3
  • 139
    • 0023942513 scopus 로고
    • Flow cytometry of epidermoid lung carcinomas: Relationship of ploidy and cell cycle phases to survival; a five-year follow up study
    • Volm M, Mattern J, Muller T, et al. Flow cytometry of epidermoid lung carcinomas: relationship of ploidy and cell cycle phases to survival; a five-year follow up study. Anticancer Res 1988; 8:105-112
    • (1988) Anticancer Res , vol.8 , pp. 105-112
    • Volm, M.1    Mattern, J.2    Muller, T.3
  • 140
    • 0023923335 scopus 로고
    • Five-year follow-up study of independent clinical and flow cytometric prognostic factors for the survival of patients with non-small cell lung carcinoma
    • Volm M, Hahn EW, Mattern J, et al. Five-year follow-up study of independent clinical and flow cytometric prognostic factors for the survival of patients with non-small cell lung carcinoma. Cancer Res 1988; 48:2923-2928
    • (1988) Cancer Res , vol.48 , pp. 2923-2928
    • Volm, M.1    Hahn, E.W.2    Mattern, J.3
  • 141
    • 0024504303 scopus 로고
    • The percentage of aneuploid cells is significantly correlated with survival in accurately staged patients with stage 1 resected squamous cell lung cancer and long-term follow up
    • van Bodegom PC, Baak JP, Stroet-van Galen C, et al. The percentage of aneuploid cells is significantly correlated with survival in accurately staged patients with stage 1 resected squamous cell lung cancer and long-term follow up. Cancer 1989; 63:143-147
    • (1989) Cancer , vol.63 , pp. 143-147
    • Van Bodegom, P.C.1    Baak, J.P.2    Stroet-van Galen, C.3
  • 142
    • 0027434477 scopus 로고
    • Prognostic significance of Ki67 labelling in resected non small cell lung cancer
    • Scagliotti GV, Micela M, Gubetta L, et al. Prognostic significance of Ki67 labelling in resected non small cell lung cancer. Eur J Cancer 1993; 29A:363-365
    • (1993) Eur J Cancer , vol.29 A , pp. 363-365
    • Scagliotti, G.V.1    Micela, M.2    Gubetta, L.3
  • 143
    • 10144220641 scopus 로고    scopus 로고
    • Hypodiploidy, Ki-67 growth fraction and prognosis of surgically resected lung cancers
    • Pujol JL, Simony J, Jolimoy G, et al. Hypodiploidy, Ki-67 growth fraction and prognosis of surgically resected lung cancers. Br J Cancer 1996; 74:964-970
    • (1996) Br J Cancer , vol.74 , pp. 964-970
    • Pujol, J.L.1    Simony, J.2    Jolimoy, G.3
  • 144
    • 0027525116 scopus 로고
    • Proliferating cell nuclear antigen expression and argyrophilic nucleolar organizer regions as factors influencing prognosis of surgically treated lung cancer patients
    • Ishida T, Kaneko S, Akazawa K, et al. Proliferating cell nuclear antigen expression and argyrophilic nucleolar organizer regions as factors influencing prognosis of surgically treated lung cancer patients. Cancer Res 1993; 53:5000-5003
    • (1993) Cancer Res , vol.53 , pp. 5000-5003
    • Ishida, T.1    Kaneko, S.2    Akazawa, K.3
  • 145
    • 0027586355 scopus 로고
    • Prognostic significance of proliferating cell nuclear antigen (PCNA) expression in non-small cell lung cancer
    • Fujii M, Motoi M, Saeki H, et al. Prognostic significance of proliferating cell nuclear antigen (PCNA) expression in non-small cell lung cancer. Acta Med Okayama 1993; 47: 103-108
    • (1993) Acta Med Okayama , vol.47 , pp. 103-108
    • Fujii, M.1    Motoi, M.2    Saeki, H.3
  • 146
    • 0344193099 scopus 로고    scopus 로고
    • Neural networks as a prognostic tool for patients with non-small cell carcinoma of the lung
    • Bellotti M, Elsner B, Paez DL, et al. Neural networks as a prognostic tool for patients with non-small cell carcinoma of the lung. Mod Pathol 1997; 10:1221-1227
    • (1997) Mod Pathol , vol.10 , pp. 1221-1227
    • Bellotti, M.1    Elsner, B.2    Paez, D.L.3
  • 147
    • 0031254556 scopus 로고    scopus 로고
    • Prognostic significance of argyrophilic nucleolar organizer region (Ag-NOR) in resected non-small cell lung cancer (NSCLC)
    • Rodrigues OR, Antonangelo L, Yagi N, et al. Prognostic significance of argyrophilic nucleolar organizer region (Ag-NOR) in resected non-small cell lung cancer (NSCLC). Jpn J Clin Oncol 1997; 27:298-304
    • (1997) Jpn J Clin Oncol , vol.27 , pp. 298-304
    • Rodrigues, O.R.1    Antonangelo, L.2    Yagi, N.3
  • 148
    • 0342547253 scopus 로고    scopus 로고
    • A prognostic model of survival in surgically resected squamous cell carcinoma of the lung using clinical, pathologic, and biologic markers
    • Bernardi FD, Antonangelo L, Beyruti R, et al. A prognostic model of survival in surgically resected squamous cell carcinoma of the lung using clinical, pathologic, and biologic markers. Mod Pathol 1997; 10:992-1000
    • (1997) Mod Pathol , vol.10 , pp. 992-1000
    • Bernardi, F.D.1    Antonangelo, L.2    Beyruti, R.3
  • 149
    • 8044259004 scopus 로고    scopus 로고
    • Morphometric evaluation of argyrophilic nucleolar organizer region is useful in predicting long-term survival in squamous cell carcinoma of the lung
    • Antonangelo L, Bernardi FD, Capelozzi VL, et al. Morphometric evaluation of argyrophilic nucleolar organizer region is useful in predicting long-term survival in squamous cell carcinoma of the lung. Chest 1997; 111:110-114
    • (1997) Chest , vol.111 , pp. 110-114
    • Antonangelo, L.1    Bernardi, F.D.2    Capelozzi, V.L.3
  • 150
    • 0025003045 scopus 로고
    • Thymidine labelling index as prognostic factor in resected non-small cell lung cancer
    • Alama A, Costantini M, Repetto L, et al. Thymidine labelling index as prognostic factor in resected non-small cell lung cancer. Eur J Cancer 1990; 26:622-625
    • (1990) Eur J Cancer , vol.26 , pp. 622-625
    • Alama, A.1    Costantini, M.2    Repetto, L.3
  • 151
    • 0025877829 scopus 로고
    • Could cell kinetics be a predictor of prognosis in non-small cell lung cancer?
    • Silvestrini R, Muscolino G, Costa A, et al. Could cell kinetics be a predictor of prognosis in non-small cell lung cancer? Lung Cancer 1991; 7:165-170
    • (1991) Lung Cancer , vol.7 , pp. 165-170
    • Silvestrini, R.1    Muscolino, G.2    Costa, A.3
  • 152
    • 0032990377 scopus 로고    scopus 로고
    • Basal cell carcinoma with lung metastasis diagnosed by fine-needle aspiration biopsy
    • Patel MS, Thigpen JT, Vance RB, et al. Basal cell carcinoma with lung metastasis diagnosed by fine-needle aspiration biopsy. South Med J 1999; 92:321-324
    • (1999) South Med J , vol.92 , pp. 321-324
    • Patel, M.S.1    Thigpen, J.T.2    Vance, R.B.3
  • 153
    • 0032521183 scopus 로고    scopus 로고
    • Expression of CD44 variant exon 6 in stage I non-small cell lung carcinoma as a prognostic factor
    • Hirata T, Fukuse T, Naiki H, et al. Expression of CD44 variant exon 6 in stage I non-small cell lung carcinoma as a prognostic factor. Cancer Res 1998; 58:1108-1110
    • (1998) Cancer Res , vol.58 , pp. 1108-1110
    • Hirata, T.1    Fukuse, T.2    Naiki, H.3
  • 154
    • 0031950315 scopus 로고    scopus 로고
    • Reduced expression of plakoglobin indicates an unfavorable prognosis in subsets of patients with non-small-cell lung cancer
    • Pantel K, Passlick B, Vogt J, et al. Reduced expression of plakoglobin indicates an unfavorable prognosis in subsets of patients with non-small-cell lung cancer. J Clin Oncol 1998; 16:1407-1413
    • (1998) J Clin Oncol , vol.16 , pp. 1407-1413
    • Pantel, K.1    Passlick, B.2    Vogt, J.3
  • 155
    • 0025074419 scopus 로고
    • K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung
    • Slebos RJ, Kibbelaar RE, Dalesio O, et al. K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. N Engl J Med 1990; 323:561-565
    • (1990) N Engl J Med , vol.323 , pp. 561-565
    • Slebos, R.J.1    Kibbelaar, R.E.2    Dalesio, O.3
  • 156
    • 0026680448 scopus 로고
    • Clinical significance of ras oncogene activation in human lung cancer
    • Rodenhuis S, Slebos RJ. Clinical significance of ras oncogene activation in human lung cancer. Cancer Res 1992; 52:2665s-2669s
    • (1992) Cancer Res , vol.52 , pp. 2665s-2669s
    • Rodenhuis, S.1    Slebos, R.J.2
  • 157
    • 0026425629 scopus 로고
    • ras gene mutations in non-small cell lung cancers are associated with shortened survival irrespective of treatment intent
    • Mitsudomi T, Steinberg SM, Oie HK, et al. ras gene mutations in non-small cell lung cancers are associated with shortened survival irrespective of treatment intent. Cancer Res 1991; 51:4999-5002
    • (1991) Cancer Res , vol.51 , pp. 4999-5002
    • Mitsudomi, T.1    Steinberg, S.M.2    Oie, H.K.3
  • 158
    • 0026533937 scopus 로고
    • Prognostic significance of the expression of ras oncogene product in non-small cell lung cancer
    • Harada M, Dosaka-Akita H, Miyamoto H, et al. Prognostic significance of the expression of ras oncogene product in non-small cell lung cancer. Cancer 1992; 69:72-77
    • (1992) Cancer , vol.69 , pp. 72-77
    • Harada, M.1    Dosaka-Akita, H.2    Miyamoto, H.3
  • 159
    • 0027293578 scopus 로고
    • The value of quality of life scores in clinical cancer research
    • Selby P. The value of quality of life scores in clinical cancer research. Eur J Cancer 1993; 29A:1656-1657
    • (1993) Eur J Cancer , vol.29 A , pp. 1656-1657
    • Selby, P.1
  • 160
    • 0031922727 scopus 로고    scopus 로고
    • Prognostic value of K-ras mutations, ras oncoprotein, and c-erb B-2 oncoprotein expression in adenocarcinoma of the lung
    • Nemunaitis J, Klemow S, Tong A, et al. Prognostic value of K-ras mutations, ras oncoprotein, and c-erb B-2 oncoprotein expression in adenocarcinoma of the lung. Am J Clin Oncol 1998; 21:155-160
    • (1998) Am J Clin Oncol , vol.21 , pp. 155-160
    • Nemunaitis, J.1    Klemow, S.2    Tong, A.3
  • 161
    • 0031908238 scopus 로고    scopus 로고
    • Mutations of p53 and K-ras genes as prognostic factors for non-small cell lung cancer
    • Huang CL, Taki T, Adachi M, et al. Mutations of p53 and K-ras genes as prognostic factors for non-small cell lung cancer. Int J Oncol 1998; 12:553-563
    • (1998) Int J Oncol , vol.12 , pp. 553-563
    • Huang, C.L.1    Taki, T.2    Adachi, M.3
  • 162
    • 0010973499 scopus 로고    scopus 로고
    • Correlation between K-ras gene mutation and prognosis of patients with nonsmall cell lung carcinoma
    • Cho JY, Kim JH, Lee YH, et al. Correlation between K-ras gene mutation and prognosis of patients with nonsmall cell lung carcinoma. Cancer 1997; 79:462-467
    • (1997) Cancer , vol.79 , pp. 462-467
    • Cho, J.Y.1    Kim, J.H.2    Lee, Y.H.3
  • 163
    • 0026654238 scopus 로고
    • ras gene mutations as a prognostic marker in adenocarcinoma of the human lung without lymph node metastasis
    • Sugio K, Ishida T, Yokoyama H, et al. ras gene mutations as a prognostic marker in adenocarcinoma of the human lung without lymph node metastasis. Cancer Res 1992; 52:2903-2906
    • (1992) Cancer Res , vol.52 , pp. 2903-2906
    • Sugio, K.1    Ishida, T.2    Yokoyama, H.3
  • 164
    • 0027473475 scopus 로고
    • Prognostic significance of p53 mutations and 3p deletions in primary resected non-small cell lung cancer
    • Horio Y, Takahashi T, Kuroishi T, et al. Prognostic significance of p53 mutations and 3p deletions in primary resected non-small cell lung cancer. Cancer Res 1993; 53:1-4
    • (1993) Cancer Res , vol.53 , pp. 1-4
    • Horio, Y.1    Takahashi, T.2    Kuroishi, T.3
  • 165
    • 0026737950 scopus 로고
    • Accumulation of p53 protein correlates with a poor prognosis in human lung cancer
    • Quinlan DC, Davidson AG, Summers CL, et al. Accumulation of p53 protein correlates with a poor prognosis in human lung cancer. Cancer Res 1992; 52:4828-4831
    • (1992) Cancer Res , vol.52 , pp. 4828-4831
    • Quinlan, D.C.1    Davidson, A.G.2    Summers, C.L.3
  • 166
    • 0027197426 scopus 로고
    • Prognostic significance of p53 protein expression and DNA ploidy in surgically treated non-small cell lung carcinomas
    • Morkve O, Halvorsen OJ, Skjaerven R, et al. Prognostic significance of p53 protein expression and DNA ploidy in surgically treated non-small cell lung carcinomas. Anticancer Res 1993; 13:571-578
    • (1993) Anticancer Res , vol.13 , pp. 571-578
    • Morkve, O.1    Halvorsen, O.J.2    Skjaerven, R.3
  • 167
    • 0027137816 scopus 로고
    • Mutations of the p53 gene as a predictor of poor prognosis in patients with non-small-cell lung cancer
    • Mitsudomi T, Oyama T, Kusano T, et al. Mutations of the p53 gene as a predictor of poor prognosis in patients with non-small-cell lung cancer. J Natl Cancer Inst 1993; 85: 2018-2023
    • (1993) J Natl Cancer Inst , vol.85 , pp. 2018-2023
    • Mitsudomi, T.1    Oyama, T.2    Kusano, T.3
  • 168
    • 0032516210 scopus 로고    scopus 로고
    • Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer
    • Huang C, Taki T, Adachi M, et al. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer. Oncogene 1998; 16:2469-2477
    • (1998) Oncogene , vol.16 , pp. 2469-2477
    • Huang, C.1    Taki, T.2    Adachi, M.3
  • 169
    • 8244225811 scopus 로고    scopus 로고
    • p53 exon 5 mutations as a prognostic indicator of shortened survival in non-small-cell lung cancer
    • Vega FJ, Iniesta P, Caldes T, et al. p53 exon 5 mutations as a prognostic indicator of shortened survival in non-small-cell lung cancer. Br J Cancer 1997; 76:44-51
    • (1997) Br J Cancer , vol.76 , pp. 44-51
    • Vega, F.J.1    Iniesta, P.2    Caldes, T.3
  • 170
    • 9044231367 scopus 로고    scopus 로고
    • Prognostic significance of abnormal p53 accumulation in primary, resected non-small-cell lung cancers
    • Nishio M, Koshikawa T, Kuroishi T, et al. Prognostic significance of abnormal p53 accumulation in primary, resected non-small-cell lung cancers. J Clin Oncol 1996; 14:497-502
    • (1996) J Clin Oncol , vol.14 , pp. 497-502
    • Nishio, M.1    Koshikawa, T.2    Kuroishi, T.3
  • 171
    • 9844241593 scopus 로고    scopus 로고
    • DNA aneuploidy, S-phase fraction, nuclear p53 positivity, and survival in non-small-cell lung carcinoma
    • Dalquen P, Moch H, Feichter G, et al. DNA aneuploidy, S-phase fraction, nuclear p53 positivity, and survival in non-small-cell lung carcinoma. Virchows Arch 1997; 431: 173-179
    • (1997) Virchows Arch , vol.431 , pp. 173-179
    • Dalquen, P.1    Moch, H.2    Feichter, G.3
  • 172
    • 0030989021 scopus 로고    scopus 로고
    • Altered retinoblastoma protein expression in nonsmall cell lung cancer: Its synergistic effects with altered ras and p53 protein status on prognosis
    • Dosaka-Akita H, Hu SX, Fujino M, et al. Altered retinoblastoma protein expression in nonsmall cell lung cancer: its synergistic effects with altered ras and p53 protein status on prognosis. Cancer 1997; 79:1329-1337
    • (1997) Cancer , vol.79 , pp. 1329-1337
    • Dosaka-Akita, H.1    Hu, S.X.2    Fujino, M.3
  • 173
    • 0030747031 scopus 로고    scopus 로고
    • p21 expression as a predictor for favorable prognosis in squamous cell carcinoma of the lung
    • Komiya T, Hosono Y, Hirashima T, et al. p21 expression as a predictor for favorable prognosis in squamous cell carcinoma of the lung. Clin Cancer Res 1997; 3:1831-1835
    • (1997) Clin Cancer Res , vol.3 , pp. 1831-1835
    • Komiya, T.1    Hosono, Y.2    Hirashima, T.3
  • 174
    • 0031049786 scopus 로고    scopus 로고
    • bcl-2 oncoprotein in surgically resected non-small cell lung cancer: Possibly favorable prognostic factor in association with low incidence of distant metastasis
    • Higashiyama M, Doi O, Kodama K, et al. bcl-2 oncoprotein in surgically resected non-small cell lung cancer: possibly favorable prognostic factor in association with low incidence of distant metastasis. J Surg Oncol 1997; 64:48-54
    • (1997) J Surg Oncol , vol.64 , pp. 48-54
    • Higashiyama, M.1    Doi, O.2    Kodama, K.3
  • 175
    • 0030940210 scopus 로고    scopus 로고
    • Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer
    • Apolinario RM, van der Valk P, de Jong JS, et al. Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer. J Clin Oncol 1997; 15:2456-2466
    • (1997) J Clin Oncol , vol.15 , pp. 2456-2466
    • Apolinario, R.M.1    Van der Valk, P.2    De Jong, J.S.3
  • 176
    • 0031963988 scopus 로고    scopus 로고
    • Prognostic value of ERBB-1, VEGF, cyclin A, FOS, JUN and MYC in patients with squamous cell lung carcinomas
    • Volm M, Rittgen W, Drings P. Prognostic value of ERBB-1, VEGF, cyclin A, FOS, JUN and MYC in patients with squamous cell lung carcinomas. Br J Cancer 1998; 77:663-669
    • (1998) Br J Cancer , vol.77 , pp. 663-669
    • Volm, M.1    Rittgen, W.2    Drings, P.3
  • 177
    • 0029789878 scopus 로고    scopus 로고
    • Does the assessment of serum markers in patients with lung cancer aid in the clinical decision making process?
    • Ebert W, Muley T, Drings P. Does the assessment of serum markers in patients with lung cancer aid in the clinical decision making process? Anticancer Res 1996; 16:2161-2168
    • (1996) Anticancer Res , vol.16 , pp. 2161-2168
    • Ebert, W.1    Muley, T.2    Drings, P.3
  • 178
    • 0029997283 scopus 로고    scopus 로고
    • Prognostic value of MIB-1 in neuroendocrine tumours of the lung
    • Bohm J, Koch S, Gais P, et al. Prognostic value of MIB-1 in neuroendocrine tumours of the lung. J Pathol 1996; 178: 402-409
    • (1996) J Pathol , vol.178 , pp. 402-409
    • Bohm, J.1    Koch, S.2    Gais, P.3
  • 179
    • 0029818514 scopus 로고    scopus 로고
    • Cytokeratins as serum markers in lung cancer: A comparison of CYFRA 21-1 and TPS
    • Pujol JL, Grenier J, Parrat E, et al. Cytokeratins as serum markers in lung cancer: a comparison of CYFRA 21-1 and TPS. Am J Respir Crit Care Med 1996; 154:725-733
    • (1996) Am J Respir Crit Care Med , vol.154 , pp. 725-733
    • Pujol, J.L.1    Grenier, J.2    Parrat, E.3
  • 180
    • 0030043947 scopus 로고    scopus 로고
    • Lung cancer chemotherapy: Response-survival relationship depends on the method of chest tumor response evaluation
    • Pujol JL, Parrat E, Lehmann M, et al. Lung cancer chemotherapy: response-survival relationship depends on the method of chest tumor response evaluation. Am J Respir Crit Care Med 1996; 153:243-249
    • (1996) Am J Respir Crit Care Med , vol.153 , pp. 243-249
    • Pujol, J.L.1    Parrat, E.2    Lehmann, M.3
  • 181
    • 0032421718 scopus 로고    scopus 로고
    • Preoperative CYFRA 21-1 level as a prognostic indicator in resected nonsmall cell lung cancer
    • Niklinski J, Burzykowski T, Niklinska W, et al. Preoperative CYFRA 21-1 level as a prognostic indicator in resected nonsmall cell lung cancer. Eur Respir J 1998; 12:1424-1428
    • (1998) Eur Respir J , vol.12 , pp. 1424-1428
    • Niklinski, J.1    Burzykowski, T.2    Niklinska, W.3
  • 182
    • 0032423812 scopus 로고    scopus 로고
    • Prognostic significance of CYFRA 21-1 in non-small cell lung cancer
    • Hirashima T, Takada M, Komiya T, et al. Prognostic significance of CYFRA 21-1 in non-small cell lung cancer. Anticancer Res 1998; 18:4713- 4716
    • (1998) Anticancer Res , vol.18 , pp. 4713-4716
    • Hirashima, T.1    Takada, M.2    Komiya, T.3
  • 183
    • 0032525120 scopus 로고    scopus 로고
    • Evaluation of tissue polypeptide specific antigen, CYFRA 21-1, and carcinoembryonic antigen in nonsmall cell lung carcinoma: Does the combined use of cytokeratin markers give any additional information?
    • Nisman B, Lafair J, Heching N, et al. Evaluation of tissue polypeptide specific antigen, CYFRA 21-1, and carcinoembryonic antigen in nonsmall cell
    • (1998) Cancer , vol.82 , pp. 1850-1859
    • Nisman, B.1    Lafair, J.2    Heching, N.3
  • 184
    • 0031105977 scopus 로고    scopus 로고
    • Diagnostic and prognostic value of CYFRA 21-1 compared with other tumour markers in patients with non-small cell lung cancer: A prospective study of 116 patients
    • Brechot JM, Chevret S, Nataf J, et al. Diagnostic and prognostic value of CYFRA 21-1 compared with other tumour markers in patients with non-small cell lung cancer: a prospective study of 116 patients. Eur J Cancer 1997; 33:385-391
    • (1997) Eur J Cancer , vol.33 , pp. 385-391
    • Brechot, J.M.1    Chevret, S.2    Nataf, J.3
  • 185
    • 0031923869 scopus 로고    scopus 로고
    • Novel staging protocol for non-small-cell lung cancers according to MRP-1/CD9 and KAI1/CD82 gene expression
    • Adachi M, Taki T, Konishi T, et al. Novel staging protocol for non-small-cell lung cancers according to MRP-1/CD9 and KAI1/CD82 gene expression. J Clin Oncol 1998; 16: 1397-1406
    • (1998) J Clin Oncol , vol.16 , pp. 1397-1406
    • Adachi, M.1    Taki, T.2    Konishi, T.3
  • 186
    • 0030972183 scopus 로고    scopus 로고
    • Immunohistochemically detected expression of motility-related protein-1 (MRP-1/CD9) in lung adenocarcinoma and its relation to prognosis
    • Higashiyama M, Doi O, Kodama K, et al. Immunohistochemically detected expression of motility-related protein-1 (MRP-1/CD9) in lung adenocarcinoma and its relation to prognosis. Int J Cancer 1997; 74:205-211
    • (1997) Int J Cancer , vol.74 , pp. 205-211
    • Higashiyama, M.1    Doi, O.2    Kodama, K.3
  • 187
    • 0029932247 scopus 로고    scopus 로고
    • Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer
    • Adachi M, Taki T, Ieki Y, et al. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer. Cancer Res 1996; 56:1751-1755
    • (1996) Cancer Res , vol.56 , pp. 1751-1755
    • Adachi, M.1    Taki, T.2    Ieki, Y.3
  • 188
    • 0027232422 scopus 로고
    • The relationship of quantitative epidermal growth factor receptor expression in non-small cell lung cancer to long term survival
    • Veale D, Kerr N, Gibson GJ, et al. The relationship of quantitative epidermal growth factor receptor expression in non-small cell lung cancer to long term survival. Br J Cancer 1993; 68:162-165
    • (1993) Br J Cancer , vol.68 , pp. 162-165
    • Veale, D.1    Kerr, N.2    Gibson, G.J.3
  • 189
    • 0025952816 scopus 로고
    • Prognostic value of c-erbB-2 protein expression in human lung adenocarcinoma and squamous cell carcinoma
    • Tateishi M, Ishida T, Mitsudomi T, et al. Prognostic value of c-erbB-2 protein expression in human lung adenocarcinoma and squamous cell carcinoma. Eur J Cancer 1991; 27:1372-1375
    • (1991) Eur J Cancer , vol.27 , pp. 1372-1375
    • Tateishi, M.1    Ishida, T.2    Mitsudomi, T.3
  • 190
    • 0025708183 scopus 로고
    • p185neu expression in human lung adenocarcinomas predicts shortened survival
    • Kern JA, Schwartz DA, Nordberg JE, et al. p185neu expression in human lung adenocarcinomas predicts shortened survival. Cancer Res 1990; 50:5184-5187
    • (1990) Cancer Res , vol.50 , pp. 5184-5187
    • Kern, J.A.1    Schwartz, D.A.2    Nordberg, J.E.3
  • 191
    • 0029790384 scopus 로고    scopus 로고
    • Hepatocyte growth factor and c-Met/hepatocyte growth factor receptor in pulmonary adenocarcinomas: An evaluation of their expression as prognostic markers
    • Takanami I, Tanana F, Hashizume T, et al. Hepatocyte growth factor and c-Met/hepatocyte growth factor receptor in pulmonary adenocarcinomas: an evaluation of their expression as prognostic markers. Oncology (Huntingt) 1996; 53:392-397
    • (1996) Oncology (Huntingt) , vol.53 , pp. 392-397
    • Takanami, I.1    Tanana, F.2    Hashizume, T.3
  • 192
    • 0031057905 scopus 로고    scopus 로고
    • Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer
    • Siegfried JM, Weissfeld LA, Singh-Kaw P, et al. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer. Cancer Res 1997; 57:433-439
    • (1997) Cancer Res , vol.57 , pp. 433-439
    • Siegfried, J.M.1    Weissfeld, L.A.2    Singh-Kaw, P.3
  • 193
    • 0030969559 scopus 로고    scopus 로고
    • Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma
    • Fontanini G, Vignati S, Boldrini L, et al. Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma. Clin Cancer Res 1997; 3:861-865
    • (1997) Clin Cancer Res , vol.3 , pp. 861-865
    • Fontanini, G.1    Vignati, S.2    Boldrini, L.3
  • 194
    • 0025793697 scopus 로고
    • Neural cell adhesion molecule expression, neuroendocrine differentiation and prognosis in lung carcinoma
    • Kibbelaar RE, Moolenaar KE, Michalides RJ, et al. Neural cell adhesion molecule expression, neuroendocrine differentiation and prognosis in lung carcinoma. Eur J Cancer 1991; 27:431-435
    • (1991) Eur J Cancer , vol.27 , pp. 431-435
    • Kibbelaar, R.E.1    Moolenaar, K.E.2    Michalides, R.J.3
  • 195
    • 0026558234 scopus 로고
    • Postoperative increase in soluble interleukin-2 receptor serum levels as predictor for early recurrence in non-small cell lung carcinoma
    • Tisi E, Lissoni P, Angeli M, et al. Postoperative increase in soluble interleukin-2 receptor serum levels as predictor for early recurrence in non-small cell lung carcinoma. Cancer 1992; 69:2458-2462
    • (1992) Cancer , vol.69 , pp. 2458-2462
    • Tisi, E.1    Lissoni, P.2    Angeli, M.3
  • 196
    • 0030794029 scopus 로고    scopus 로고
    • Prognostic significance of cyclin D1 and retinoblastoma expression in combination with p53 abnormalities in primary, resected non-small cell lung cancers
    • Nishio M, Koshikawa T, Yatabe Y, et al. Prognostic significance of cyclin D1 and retinoblastoma expression in combination with p53 abnormalities in primary, resected non-small cell lung cancers. Clin Cancer Res 1997; 3:1051-1058
    • (1997) Clin Cancer Res , vol.3 , pp. 1051-1058
    • Nishio, M.1    Koshikawa, T.2    Yatabe, Y.3
  • 197
    • 0030043970 scopus 로고    scopus 로고
    • Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer
    • Betticher DC, Heighway J, Hasleton PS, et al. Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer. Br J Cancer 1996; 73:294-300
    • (1996) Br J Cancer , vol.73 , pp. 294-300
    • Betticher, D.C.1    Heighway, J.2    Hasleton, P.S.3
  • 198
    • 0030809321 scopus 로고    scopus 로고
    • Prognostic role of cyclin D1 in non small cell lung cancer: An immunohistochemical analysis
    • Caputi M, De Luca L, Papaccio G, et al. Prognostic role of cyclin D1 in non small cell lung cancer: an immunohistochemical analysis. Eur J Histochem 1997; 41:133-138
    • (1997) Eur J Histochem , vol.41 , pp. 133-138
    • Caputi, M.1    De Luca, L.2    Papaccio, G.3
  • 199
    • 0030920937 scopus 로고    scopus 로고
    • Influence of cathepsin D expression in lung adenocarcinoma on prognosis: Possible importance of its expression in tumor cells and stromal cells, and its intracellular polarization in tumor cells
    • Higashiyama M, Doi O, Kodama K, et al. Influence of cathepsin D expression in lung adenocarcinoma on prognosis: possible importance of its expression in tumor cells and stromal cells, and its intracellular polarization in tumor cells. J Surg Oncol 1997; 65:10-19
    • (1997) J Surg Oncol , vol.65 , pp. 10-19
    • Higashiyama, M.1    Doi, O.2    Kodama, K.3
  • 200
    • 0025897013 scopus 로고
    • Prognostic significance of basement membrane deposition in operable squamous cell carcinomas of the lung
    • Ten Velde GP, Havenith MG, Volovics A, et al. Prognostic significance of basement membrane deposition in operable squamous cell carcinomas of the lung. Cancer 1991; 67: 3001-3005
    • (1991) Cancer , vol.67 , pp. 3001-3005
    • Ten Velde, G.P.1    Havenith, M.G.2    Volovics, A.3
  • 201
    • 0026639138 scopus 로고
    • Significance of perioperative blood transfusions in patients undergoing resection of stage I and II non-small-cell lung cancers
    • Pena CM, Rice TW, Ahmad M, et al. Significance of perioperative blood transfusions in patients undergoing resection of stage I and II non-small-cell lung cancers. Chest 1992; 102:84-88
    • (1992) Chest , vol.102 , pp. 84-88
    • Pena, C.M.1    Rice, T.W.2    Ahmad, M.3
  • 202
    • 0027325871 scopus 로고
    • Prognosis of unsuspected but completely resectable N2 non-small cell lung cancer
    • van Klaveren RJ, Festen J, Otten HJ, et al. Prognosis of unsuspected but completely resectable N2 non-small cell lung cancer. Ann Thorac Surg 1993; 56:300-304
    • (1993) Ann Thorac Surg , vol.56 , pp. 300-304
    • Van Klaveren, R.J.1    Festen, J.2    Otten, H.J.3
  • 203
    • 0027305459 scopus 로고
    • Expression of carbohydrate antigens in human pulmonary adenocarcinoma
    • Kawai T, Suzuki M, Kase K, et al. Expression of carbohydrate antigens in human pulmonary adenocarcinoma. Cancer 1993; 72:1581-1587
    • (1993) Cancer , vol.72 , pp. 1581-1587
    • Kawai, T.1    Suzuki, M.2    Kase, K.3
  • 204
    • 0028884881 scopus 로고
    • Prognostic significance of p53 and ras p21 expression in nonsmall cell lung cancer
    • Fujino M, Dosaka-Akita H, Harada M, et al. Prognostic significance of p53 and ras p21 expression in nonsmall cell lung cancer. Cancer 1995; 76:2457-2463
    • (1995) Cancer , vol.76 , pp. 2457-2463
    • Fujino, M.1    Dosaka-Akita, H.2    Harada, M.3
  • 205
    • 0030033010 scopus 로고    scopus 로고
    • p53 protein in non-small cell lung cancer as quantitated by enzyme-linked immunosorbent assay: Relation to prognosis
    • Pappot H, Francis D, Brunner N, et al. p53 protein in non-small cell lung cancer as quantitated by enzyme-linked immunosorbent assay: relation to prognosis. Clin Cancer Res 1996; 2:155-160
    • (1996) Clin Cancer Res , vol.2 , pp. 155-160
    • Pappot, H.1    Francis, D.2    Brunner, N.3
  • 206
    • 0029889028 scopus 로고    scopus 로고
    • Loss of heterozygosity at 3p in non-small cell lung cancer and its prognostic implication
    • Mitsudomi T, Oyama T, Nishida K, et al. Loss of heterozygosity at 3p in non-small cell lung cancer and its prognostic implication. Clin Cancer Res 1996; 2:1185-1189
    • (1996) Clin Cancer Res , vol.2 , pp. 1185-1189
    • Mitsudomi, T.1    Oyama, T.2    Nishida, K.3
  • 207
    • 13244300654 scopus 로고    scopus 로고
    • Nuclear p53 overexpression is an independent prognostic parameter in node-negative non-small cell lung carcinoma
    • Dalquen P, Sauter G, Torhorst J, et al. Nuclear p53 overexpression is an independent prognostic parameter in node-negative non-small cell lung carcinoma. J Pathol 1996; 178:53-58
    • (1996) J Pathol , vol.178 , pp. 53-58
    • Dalquen, P.1    Sauter, G.2    Torhorst, J.3
  • 208
    • 0030009321 scopus 로고    scopus 로고
    • Insulin-like growth factor-II as a prognostic factor in pulmonary adenocarcinoma
    • Takanami I, Imamuma T, Hashizume T, et al. Insulin-like growth factor-II as a prognostic factor in pulmonary adenocarcinoma. J Surg Oncol 1996; 61:205-208
    • (1996) J Surg Oncol , vol.61 , pp. 205-208
    • Takanami, I.1    Imamuma, T.2    Hashizume, T.3
  • 209
    • 0031051964 scopus 로고    scopus 로고
    • Transforming growth factor-beta isoforms expressions in pulmonary adenocarcinomas as prognostic markers: An immunohistological study of one hundred and twenty patients
    • Takanami I, Tanaka F, Hashizume T, et al. Transforming growth factor-beta isoforms expressions in pulmonary adenocarcinomas as prognostic markers: an immunohistological study of one hundred and twenty patients. Oncology (Huntingt) 1997; 54:122-128
    • (1997) Oncology (Huntingt) , vol.54 , pp. 122-128
    • Takanami, I.1    Tanaka, F.2    Hashizume, T.3
  • 210
    • 0030993406 scopus 로고    scopus 로고
    • Selection mechanisms as major determinants of survival after pulmonary metastasectomy
    • Aberg T. Selection mechanisms as major determinants of survival after pulmonary metastasectomy. Ann Thorac Surg 1997; 63:611-612
    • (1997) Ann Thorac Surg , vol.63 , pp. 611-612
    • Aberg, T.1
  • 211
    • 0031041776 scopus 로고    scopus 로고
    • Blood group antigen A and flow cytometric analysis in resected early-stage non-small cell lung cancer
    • Graziano SL, Tatum AH, Gonchoroff NJ, et al. Blood group antigen A and flow cytometric analysis in resected early-stage non-small cell lung cancer. Clin Cancer Res 1997; 3:87-93
    • (1997) Clin Cancer Res , vol.3 , pp. 87-93
    • Graziano, S.L.1    Tatum, A.H.2    Gonchoroff, N.J.3
  • 212
    • 0031037304 scopus 로고    scopus 로고
    • Autologous tumor killing activity as a prognostic factor in primary resected nonsmall cell carcinoma of the lung
    • Fujisawa T, Yamaguchi Y. Autologous tumor killing activity as a prognostic factor in primary resected nonsmall cell carcinoma of the lung. Cancer 1997; 79:474-481
    • (1997) Cancer , vol.79 , pp. 474-481
    • Fujisawa, T.1    Yamaguchi, Y.2
  • 213
    • 0031467589 scopus 로고    scopus 로고
    • Prognostic significance of serum p53 antibodies in squamous cell carcinoma of the lung
    • Komiya T, Hirashima T, Takada M, et al. Prognostic significance of serum p53 antibodies in squamous cell carcinoma of the lung. Anticancer Res 1997; 17:3721-3724
    • (1997) Anticancer Res , vol.17 , pp. 3721-3724
    • Komiya, T.1    Hirashima, T.2    Takada, M.3
  • 214
    • 0031594754 scopus 로고    scopus 로고
    • Reduced integrin alpha3 expression as a factor of poor prognosis of patients with adenocarcinoma of the lung
    • Adachi M, Taki T, Huang C, et al. Reduced integrin alpha3 expression as a factor of poor prognosis of patients with adenocarcinoma of the lung. J Clin Oncol 1998; 16:1060-1067
    • (1998) J Clin Oncol , vol.16 , pp. 1060-1067
    • Adachi, M.1    Taki, T.2    Huang, C.3
  • 215
    • 0032858245 scopus 로고    scopus 로고
    • Prognostic significance of apoptotic index in completely resected non-small-cell lung cancer
    • Tanaka F, Kawano Y, Li M, et al. Prognostic significance of apoptotic index in completely resected non-small-cell lung cancer. J Clin Oncol 1999; 17:2728-2736
    • (1999) J Clin Oncol , vol.17 , pp. 2728-2736
    • Tanaka, F.1    Kawano, Y.2    Li, M.3
  • 216
    • 0032888251 scopus 로고    scopus 로고
    • Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer: An analysis of 125 cases
    • Vansteenkiste JF, Stroobants SG, Dupont PJ, et al. Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer: an analysis of 125 cases. J Clin Oncol 1999; 17:3201-3206
    • (1999) J Clin Oncol , vol.17 , pp. 3201-3206
    • Vansteenkiste, J.F.1    Stroobants, S.G.2    Dupont, P.J.3
  • 217
    • 0033570968 scopus 로고    scopus 로고
    • Conventional clinicopathologic prognostic factors in surgically resected nonsmall cell lung carcinoma: A comparison of prognostic factors for each pathologic TNM stage based on multivariate analyses
    • Suzuki K, Nagai K, Yoshida J, et al. Conventional clinicopathologic prognostic factors in surgically resected nonsmall cell lung carcinoma: a comparison of prognostic factors for each pathologic TNM stage based on multivariate analyses. Cancer 1999; 86:1976-1984
    • (1999) Cancer , vol.86 , pp. 1976-1984
    • Suzuki, K.1    Nagai, K.2    Yoshida, J.3
  • 218
    • 0033498902 scopus 로고    scopus 로고
    • Prognostic impact of telomerase activity in non-small cell lung cancers
    • Taga S, Osaki T, Ohgami A, et al. Prognostic impact of telomerase activity in non-small cell lung cancers. Ann Surg 1999; 230:715-720
    • (1999) Ann Surg , vol.230 , pp. 715-720
    • Taga, S.1    Osaki, T.2    Ohgami, A.3
  • 219
    • 0032743861 scopus 로고    scopus 로고
    • Non-small cell lung cancer: Prognostic factors in patients treated with surgery and postoperative radiation therapy
    • Lee JH, Machtay M, Kaiser LR, et al. Non-small cell lung cancer: prognostic factors in patients treated with surgery and postoperative radiation therapy. Radiology 1999; 213: 845-852
    • (1999) Radiology , vol.213 , pp. 845-852
    • Lee, J.H.1    Machtay, M.2    Kaiser, L.R.3
  • 220
    • 0033485503 scopus 로고    scopus 로고
    • Implications and prognostic value of K-ras mutation for early-stage lung cancer in women
    • Nelson HH, Christiani DC, Mark EJ, et al. Implications and prognostic value of K-ras mutation for early-stage lung cancer in women. J Natl Cancer Inst 1999; 91:2032-2038
    • (1999) J Natl Cancer Inst , vol.91 , pp. 2032-2038
    • Nelson, H.H.1    Christiani, D.C.2    Mark, E.J.3
  • 221
    • 0033229836 scopus 로고    scopus 로고
    • p53 null mutations undetected by immunohistochemical staining predict a poor outcome with early-stage non-small cell lung carcinomas
    • Hashimoto T, Tokuchi Y, Hayashi M, et al. p53 null mutations undetected by immunohistochemical staining predict a poor outcome with early-stage non-small cell lung carcinomas. Cancer Res 1999; 59:5572-5577
    • (1999) Cancer Res , vol.59 , pp. 5572-5577
    • Hashimoto, T.1    Tokuchi, Y.2    Hayashi, M.3
  • 222
    • 0032886024 scopus 로고    scopus 로고
    • Predictive value of expression of p16INK4A, retinoblastoma and p53 proteins for the prognosis of non-small-cell lung cancers
    • Hommura F, Dosaka-Akita H, Kinoshita I, et al. Predictive value of expression of p16INK4A, retinoblastoma and p53 proteins for the prognosis of non-small-cell lung cancers. Br J Cancer 1999; 81:696-701
    • (1999) Br J Cancer , vol.81 , pp. 696-701
    • Hommura, F.1    Dosaka-Akita, H.2    Kinoshita, I.3
  • 223
    • 0032872258 scopus 로고    scopus 로고
    • Immunochemical analysis of cathepsin B in lung tumours: An independent prognostic factor for squamous cell carcinoma patients
    • Werle B, Lotterle H, Schanzenbacher U, et al. Immunochemical analysis of cathepsin B in lung tumours: an independent prognostic factor for squamous cell carcinoma patients. Br J Cancer 1999; 81:510-519
    • (1999) Br J Cancer , vol.81 , pp. 510-519
    • Werle, B.1    Lotterle, H.2    Schanzenbacher, U.3
  • 224
    • 0032886757 scopus 로고    scopus 로고
    • Independent prognostic role of p16 expression in lung cancer
    • Groeger AM, Caputi M, Esposito V, et al. Independent prognostic role of p16 expression in lung cancer. Thorac Cardiovasc Surg 1999; 118:529-535
    • (1999) Thorac Cardiovasc Surg , vol.118 , pp. 529-535
    • Groeger, A.M.1    Caputi, M.2    Esposito, V.3
  • 225
    • 0032818807 scopus 로고    scopus 로고
    • Patients with stage I non-small cell lung carcinoma at postoperative risk for local recurrence, distant metastasis, and death: Implications related to the design of clinical trials
    • Sawyer TE, Bonner JA, Gould PM, et al. Patients with stage I non-small cell lung carcinoma at postoperative risk for local recurrence, distant metastasis, and death: implications related to the design of clinical trials. Int J Radiat Oncol Biol Phys 1999; 45:315-321
    • (1999) Int J Radiat Oncol Biol Phys , vol.45 , pp. 315-321
    • Sawyer, T.E.1    Bonner, J.A.2    Gould, P.M.3
  • 226
    • 0032758942 scopus 로고    scopus 로고
    • Evaluation of TMN classification for lung carcinoma with ipsilateral intrapulmonary metastasis
    • Okada M, Tsubota N, Yoshimura M, et al. Evaluation of TMN classification for lung carcinoma with ipsilateral intrapulmonary metastasis. Ann Thorac Surg 1999; 68:326-330
    • (1999) Ann Thorac Surg , vol.68 , pp. 326-330
    • Okada, M.1    Tsubota, N.2    Yoshimura, M.3
  • 227
    • 0032928142 scopus 로고    scopus 로고
    • Disseminated tumor cells in lymph nodes as a determinant for survival in surgically resected non-small-cell lung cancer
    • Kubuschok B, Passlick B, Izbicki JR, et al. Disseminated tumor cells in lymph nodes as a determinant for survival in surgically resected non-small-cell lung cancer. J Clin Oncol 1999; 17:19-24
    • (1999) J Clin Oncol , vol.17 , pp. 19-24
    • Kubuschok, B.1    Passlick, B.2    Izbicki, J.R.3
  • 228
    • 0033002559 scopus 로고    scopus 로고
    • Preoperative CEA, NSE, SCC, TPA and CYFRA 21.1 serum levels as prognostic indicators in resected non-small cell lung cancer
    • Foa P, Fornier M, Miceli R, et al. Preoperative CEA, NSE, SCC, TPA and CYFRA 21.1 serum levels as prognostic indicators in resected non-small cell lung cancer. Int J Biol Markers 1999; 14:92-98
    • (1999) Int J Biol Markers , vol.14 , pp. 92-98
    • Foa, P.1    Fornier, M.2    Miceli, R.3
  • 229
    • 0032900873 scopus 로고    scopus 로고
    • Prognostic significance of allelic imbalances on chromosome 9p in stage I non-small cell lung carcinoma
    • Tomizawa Y, Adachi J, Kohno T, et al. Prognostic significance of allelic imbalances on chromosome 9p in stage I non-small cell lung carcinoma. Clin Cancer Res 1999; 5:1139-1146
    • (1999) Clin Cancer Res , vol.5 , pp. 1139-1146
    • Tomizawa, Y.1    Adachi, J.2    Kohno, T.3
  • 230
    • 0032779721 scopus 로고    scopus 로고
    • Unfavorable prognosis of patients with stage II non-small cell lung cancer associated with macroscopic nodal metastases
    • Yoshino I, Nakanishi R, Osaki T, et al. Unfavorable prognosis of patients with stage II non-small cell lung cancer associated with macroscopic nodal metastases. Chest 1999; 116:144-149
    • (1999) Chest , vol.116 , pp. 144-149
    • Yoshino, I.1    Nakanishi, R.2    Osaki, T.3
  • 231
    • 0032991727 scopus 로고    scopus 로고
    • The prognosis of surgically resected N2 non-small cell lung cancer: The importance of clinical N status
    • Suzuki K, Nagai K, Yoshida J, et al. The prognosis of surgically resected N2 non-small cell lung cancer: the importance of clinical N status. Thorac Cardiovasc Surg 1999; 118:145-153
    • (1999) Thorac Cardiovasc Surg , vol.118 , pp. 145-153
    • Suzuki, K.1    Nagai, K.2    Yoshida, J.3
  • 232
    • 0032937689 scopus 로고    scopus 로고
    • p53 status predicts the efficacy of postoperative oral administration of tegafur for completely resected non-small cell lung cancer
    • Tanaka F, Yanagihara K, Ohtake Y, et al. p53 status predicts the efficacy of postoperative oral administration of tegafur for completely resected non-small cell lung cancer. Jpn J Cancer Res 1999; 90:432-438
    • (1999) Jpn J Cancer Res , vol.90 , pp. 432-438
    • Tanaka, F.1    Yanagihara, K.2    Ohtake, Y.3
  • 233
    • 0033163313 scopus 로고    scopus 로고
    • Prognostic significance of different biomarkers in non-small cell lung cancer
    • Lavezzi AM, Santambrogio L, Bellaviti N, et al. Prognostic significance of different biomarkers in non-small cell lung cancer. Oncol Rep 1999; 6:819-825
    • (1999) Oncol Rep , vol.6 , pp. 819-825
    • Lavezzi, A.M.1    Santambrogio, L.2    Bellaviti, N.3
  • 234
    • 0033015810 scopus 로고    scopus 로고
    • Study of prognostic predictors for non-small cell lung cancer
    • Fu XL, Zhu XZ, Shi DR, et al. Study of prognostic predictors for non-small cell lung cancer. Lung Cancer 1999; 23:143-152
    • (1999) Lung Cancer , vol.23 , pp. 143-152
    • Fu, X.L.1    Zhu, X.Z.2    Shi, D.R.3
  • 235
    • 0033535615 scopus 로고    scopus 로고
    • A novel molecular staging protocol for non-small cell lung cancer
    • Miyake M, Adachi M, Huang C, et al. A novel molecular staging protocol for non-small cell lung cancer. Oncogene 1999; 18:2397-2404
    • (1999) Oncogene , vol.18 , pp. 2397-2404
    • Miyake, M.1    Adachi, M.2    Huang, C.3
  • 236
    • 0032915390 scopus 로고    scopus 로고
    • Relation between the serum E-selectin level and the survival rate of patients with resected non-small cell lung cancers
    • Tsumatori G, Ozeki Y, Takagi K, et al. Relation between the serum E-selectin level and the survival rate of patients with resected non-small cell lung cancers. Jpn J Cancer Res 1999; 90:301-307
    • (1999) Jpn J Cancer Res , vol.90 , pp. 301-307
    • Tsumatori, G.1    Ozeki, Y.2    Takagi, K.3
  • 237
    • 0032949196 scopus 로고    scopus 로고
    • Expression of bcl-2 protein in non-small cell lung cancer: Correlation with clinicopathology and patient survival
    • Laudanski J, Chyczewski L, Niklinska WE, et al. Expression of bcl-2 protein in non-small cell lung cancer: correlation with clinicopathology and patient survival. Neoplasma 1999; 46:25-30
    • (1999) Neoplasma , vol.46 , pp. 25-30
    • Laudanski, J.1    Chyczewski, L.2    Niklinska, W.E.3
  • 238
    • 0344915156 scopus 로고    scopus 로고
    • Expression of Fas (CD95/APO-1) and Fas ligand in lung cancer, its prognostic and predictive relevance
    • Koomagi R, Volm M. Expression of Fas (CD95/APO-1) and Fas ligand in lung cancer, its prognostic and predictive relevance. Int J Cancer 1999; 84:239-243
    • (1999) Int J Cancer , vol.84 , pp. 239-243
    • Koomagi, R.1    Volm, M.2
  • 239
    • 0032970313 scopus 로고    scopus 로고
    • Prognostic value of thyroid transcription factor-1 in primary, resected, non-small cell lung carcinoma
    • Puglisi F, Barbone F, Damante G, et al. Prognostic value of thyroid transcription factor-1 in primary, resected, non-small cell lung carcinoma. Mod Pathol 1999; 12:318-324
    • (1999) Mod Pathol , vol.12 , pp. 318-324
    • Puglisi, F.1    Barbone, F.2    Damante, G.3
  • 240
    • 0032915271 scopus 로고    scopus 로고
    • Prognostic factors in clinical stage I non-small cell lung cancer
    • Suzuki K, Nagai K, Yoshida J, et al. Prognostic factors in clinical stage I non-small cell lung cancer. Ann Thorac Surg 1999; 67:927-932
    • (1999) Ann Thorac Surg , vol.67 , pp. 927-932
    • Suzuki, K.1    Nagai, K.2    Yoshida, J.3
  • 241
    • 0032766423 scopus 로고    scopus 로고
    • Telomerase activity as a prognostic indicator in stage I non-small cell lung cancer
    • Marchetti A, Bertacca G, Buttitta F, et al. Telomerase activity as a prognostic indicator in stage I non-small cell lung cancer. Clin Cancer Res 1999; 5:2077-2081
    • (1999) Clin Cancer Res , vol.5 , pp. 2077-2081
    • Marchetti, A.1    Bertacca, G.2    Buttitta, F.3
  • 242
    • 0033455515 scopus 로고    scopus 로고
    • Prognostic value of CYFRA 21-1, TPS and CEA in different histologic types of non-small cell lung cancer
    • Nisman B, Amir G, Lafair J, et al. Prognostic value of CYFRA 21-1, TPS and CEA in different histologic types of non-small cell lung cancer. Anticancer Res 1999; 19:3549-3552
    • (1999) Anticancer Res , vol.19 , pp. 3549-3552
    • Nisman, B.1    Amir, G.2    Lafair, J.3
  • 243
    • 0033024370 scopus 로고    scopus 로고
    • Smoking before surgery predicts poor long-term survival in patients with stage I non-small-cell lung carcinomas
    • Fujisawa T, Iizasa T, Saitoh Y, et al. Smoking before surgery predicts poor long-term survival in patients with stage I non-small-cell lung carcinomas. J Clin Oncol 1999; 17:2086-2091
    • (1999) J Clin Oncol , vol.17 , pp. 2086-2091
    • Fujisawa, T.1    Iizasa, T.2    Saitoh, Y.3
  • 244
    • 0033428435 scopus 로고    scopus 로고
    • Tumour markers CEA, NSE, SCC, TPA and CYFRA 21.1 in resectable non-small cell lung cancer
    • Foa P, Fornier M, Miceli R, et al. Tumour markers CEA, NSE, SCC, TPA and CYFRA 21.1 in resectable non-small cell lung cancer. Anticancer Res 1999; 19:3613-3618
    • (1999) Anticancer Res , vol.19 , pp. 3613-3618
    • Foa, P.1    Fornier, M.2    Miceli, R.3
  • 245
    • 0033776521 scopus 로고    scopus 로고
    • 'Invading edge vs. inner' (edvin) patterns of vascularization: An interplay between angiogenic and vascular survival factors defines the clinical behaviour of non-small cell lung cancer
    • Giatromanolaki A, Koukourakis MI, Sivridis E, et al. 'Invading edge vs. inner' (edvin) patterns of vascularization: an interplay between angiogenic and vascular survival factors defines the clinical behaviour of non-small cell lung cancer. J Pathol 2000; 192:140-149
    • (2000) J Pathol , vol.192 , pp. 140-149
    • Giatromanolaki, A.1    Koukourakis, M.I.2    Sivridis, E.3
  • 246
    • 0033869662 scopus 로고    scopus 로고
    • Prognostic significance of telomeric repeat length alterations in pathological stage I-IIIA non-small cell lung cancer
    • Hirashima T, Komiya T, Nitta T, et al. Prognostic significance of telomeric repeat length alterations in pathological stage I-IIIA non-small cell lung cancer. Anticancer Res 2000; 20:2181-2187
    • (2000) Anticancer Res , vol.20 , pp. 2181-2187
    • Hirashima, T.1    Komiya, T.2    Nitta, T.3
  • 247
    • 0342433777 scopus 로고    scopus 로고
    • Hypoxia-inducible factor (HIF-1) and its relationship to apoptosis and proliferation in lung cancer
    • Volm M, Koomagi R. Hypoxia-inducible factor (HIF-1) and its relationship to apoptosis and proliferation in lung cancer. Anticancer Res 2000; 20:1527-1533
    • (2000) Anticancer Res , vol.20 , pp. 1527-1533
    • Volm, M.1    Koomagi, R.2
  • 248
    • 0034012454 scopus 로고    scopus 로고
    • Natural autoantibody to MUC1 is a prognostic indicator for non-small cell lung cancer
    • Hirasawa Y, Kohno N, Yokoyama A, et al. Natural autoantibody to MUC1 is a prognostic indicator for non-small cell lung cancer. Am J Respir Crit Care Med 2000; 161:589-594
    • (2000) Am J Respir Crit Care Med , vol.161 , pp. 589-594
    • Hirasawa, Y.1    Kohno, N.2    Yokoyama, A.3
  • 249
    • 18744431008 scopus 로고    scopus 로고
    • Biological prognostic factors for early stage completely resected non-small cell lung cancer
    • Cagini L, Monacelli M, Giustozzi G, et al. Biological prognostic factors for early stage completely resected non-small cell lung cancer. J Surg Oncol 2000; 74:53-60
    • (2000) J Surg Oncol , vol.74 , pp. 53-60
    • Cagini, L.1    Monacelli, M.2    Giustozzi, G.3
  • 250
    • 18744434862 scopus 로고    scopus 로고
    • Epidermal growth factor receptor expression correlates with poor prognosis in non-small cell lung cancer patients with p53 overexpression
    • Ohsaki Y, Tanno S, Fujita Y, et al. Epidermal growth factor receptor expression correlates with poor prognosis in non-small cell lung cancer patients with p53 overexpression. Oncol Rep 2000; 7:603-607
    • (2000) Oncol Rep , vol.7 , pp. 603-607
    • Ohsaki, Y.1    Tanno, S.2    Fujita, Y.3
  • 251
    • 0034078113 scopus 로고    scopus 로고
    • Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma
    • Oyama T, Osaki T, Nose N, et al. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma. Anticancer Res 2000; 20:505-510
    • (2000) Anticancer Res , vol.20 , pp. 505-510
    • Oyama, T.1    Osaki, T.2    Nose, N.3
  • 252
    • 0034024352 scopus 로고    scopus 로고
    • Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer
    • O'Byrne KJ, Koukourakis MI, Giatromanolaki A, et al. Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer. Br J Cancer 2000; 82:1427-1432
    • (2000) Br J Cancer , vol.82 , pp. 1427-1432
    • O'Byrne, K.J.1    Koukourakis, M.I.2    Giatromanolaki, A.3
  • 253
    • 0033977670 scopus 로고    scopus 로고
    • p16 protein expression is associated with a poor prognosis in squamous cell carcinoma of the lung
    • Huang CI, Taki T, Higashiyama M, et al. p16 protein expression is associated with a poor prognosis in squamous cell carcinoma of the lung. Br J Cancer 2000; 82:374-380
    • (2000) Br J Cancer , vol.82 , pp. 374-380
    • Huang, C.I.1    Taki, T.2    Higashiyama, M.3
  • 254
    • 0033915743 scopus 로고    scopus 로고
    • Tumour necrosis factor-alpha and transforming growth factor-beta are significantly associated with better prognosis in non-small cell lung carcinoma: Putative relation with BCL-2-mediated neovascularization
    • Boldrini L, Calcinai A, Samaritani E, et al. Tumour necrosis factor-alpha and transforming growth factor-beta are significantly associated with better prognosis in non-small cell lung carcinoma: putative relation with BCL-2-mediated neovascularization. Br J Cancer 2000; 83:480-486
    • (2000) Br J Cancer , vol.83 , pp. 480-486
    • Boldrini, L.1    Calcinai, A.2    Samaritani, E.3
  • 255
    • 0033931517 scopus 로고    scopus 로고
    • Multiple molecular marker testing (p53, C-Ki-ras, c-erbB-2) improves estimation of prognosis in potentially curative resected non-small cell lung cancer
    • Schneider PM, Praeuer HW, Stoeltzing O, et al. Multiple molecular marker testing (p53, C-Ki-ras, c-erbB-2) improves estimation of prognosis in potentially curative resected non-small cell lung cancer. Br J Cancer 2000; 83:473-479
    • (2000) Br J Cancer , vol.83 , pp. 473-479
    • Schneider, P.M.1    Praeuer, H.W.2    Stoeltzing, O.3
  • 256
    • 0033947298 scopus 로고    scopus 로고
    • Prognostic significance of proliferative activity in pN2 non-small-cell lung carcinomas and their mediastinal lymph node metastases
    • Fukuse T, Hirata T, Naiki H, et al. Prognostic significance of proliferative activity in pN2 non-small-cell lung carcinomas and their mediastinal lymph node metastases. Ann Surg 2000; 232:112-118
    • (2000) Ann Surg , vol.232 , pp. 112-118
    • Fukuse, T.1    Hirata, T.2    Naiki, H.3
  • 257
    • 0034131071 scopus 로고    scopus 로고
    • Prognostic value of the quantified expression of p185 in non-small cell lung cancer
    • Cantero R, Torres AJ, Maestro ML, et al. Prognostic value of the quantified expression of p185 in non-small cell lung cancer. Thorac Cardiovasc Surg 2000; 119:1119-1125
    • (2000) Thorac Cardiovasc Surg , vol.119 , pp. 1119-1125
    • Cantero, R.1    Torres, A.J.2    Maestro, M.L.3
  • 258
    • 0033968335 scopus 로고    scopus 로고
    • Cyclin E expression, a potential prognostic marker for non-small cell lung cancers
    • Mishina T, Dosaka-Akita H, Hommura F, et al. Cyclin E expression, a potential prognostic marker for non-small cell lung cancers. Clin Cancer Res 2000; 6:11-16
    • (2000) Clin Cancer Res , vol.6 , pp. 11-16
    • Mishina, T.1    Dosaka-Akita, H.2    Hommura, F.3
  • 259
    • 0034100054 scopus 로고    scopus 로고
    • Predictive survival markers in patients with surgically resected non-small cell lung carcinoma
    • Moldvay J, Scheid P, Wild P, et al. Predictive survival markers in patients with surgically resected non-small cell lung carcinoma. Clin Cancer Res 2000; 6:1125-1134
    • (2000) Clin Cancer Res , vol.6 , pp. 1125-1134
    • Moldvay, J.1    Scheid, P.2    Wild, P.3
  • 260
    • 0034100053 scopus 로고    scopus 로고
    • p53 mutations in defined structural and functional domains are related to poor clinical outcome in non-small cell lung cancer patients
    • Skaug V, Ryberg D, Kure EH, et al. p53 mutations in defined structural and functional domains are related to poor clinical outcome in non-small cell lung cancer patients. Clin Cancer Res 2000; 6:1031-1037
    • (2000) Clin Cancer Res , vol.6 , pp. 1031-1037
    • Skaug, V.1    Ryberg, D.2    Kure, E.H.3
  • 261
    • 0034056981 scopus 로고    scopus 로고
    • Vascular endothelial growth factor expression and neovascularisation in non-small cell lung cancer
    • Yano T, Tanikawa S, Fujie T, et al. Vascular endothelial growth factor expression and neovascularisation in non-small cell lung cancer. Eur J Cancer 2000; 36:601-609
    • (2000) Eur J Cancer , vol.36 , pp. 601-609
    • Yano, T.1    Tanikawa, S.2    Fujie, T.3
  • 262
    • 0033890742 scopus 로고    scopus 로고
    • Survival of patients with resected N2 non-small-cell lung cancer: Evidence for a subclassification and implications
    • Andre F, Grunenwald D, Pignon JP, et al. Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications. J Clin Oncol 2000; 18:2981-2989
    • (2000) J Clin Oncol , vol.18 , pp. 2981-2989
    • Andre, F.1    Grunenwald, D.2    Pignon, J.P.3
  • 263
    • 0034489809 scopus 로고    scopus 로고
    • Expression of E-cadherin and beta-catenin in human non-small cell lung cancer and the clinical significance
    • Kase S, Sugio K, Yamazaki K, et al. Expression of E-cadherin and beta-catenin in human non-small cell lung cancer and the clinical significance. Clin Cancer Res 2000; 6:4789-4796
    • (2000) Clin Cancer Res , vol.6 , pp. 4789-4796
    • Kase, S.1    Sugio, K.2    Yamazaki, K.3
  • 264
    • 0034523656 scopus 로고    scopus 로고
    • Ploidy, expression of erbB1, erbB2, P53 and amplification of erbB1, erbB2 and erbB3 in non-small cell lung cancer
    • Reinmuth N, Brandt B, Kunze WP, et al. Ploidy, expression of erbB1, erbB2, P53 and amplification of erbB1, erbB2 and erbB3 in non-small cell lung cancer. Eur Respir J 2000; 16:991-996
    • (2000) Eur Respir J , vol.16 , pp. 991-996
    • Reinmuth, N.1    Brandt, B.2    Kunze, W.P.3
  • 265
    • 0034237253 scopus 로고    scopus 로고
    • Influence of age and predicted forced expiratory volume in 1 s on prognosis following complete resection for non-small cell lung carcinoma
    • Varela G, Novoa N, Jimenez MF. Influence of age and predicted forced expiratory volume in 1 s on prognosis following complete resection for non-small cell lung carcinoma. Eur J Cardiothorac Surg 2000; 18:2-6
    • (2000) Eur J Cardiothorac Surg , vol.18 , pp. 2-6
    • Varela, G.1    Novoa, N.2    Jimenez, M.F.3
  • 266
    • 0034118679 scopus 로고    scopus 로고
    • p53 gene mutation and protein expression in operable non-small cell lung cancer in Poland
    • Niklinska W, Burzykowski T, Chyczewski L, et al. p53 gene mutation and protein expression in operable non-small cell lung cancer in Poland. Eur J Cancer Prev 2000; 9:81-87
    • (2000) Eur J Cancer Prev , vol.9 , pp. 81-87
    • Niklinska, W.1    Burzykowski, T.2    Chyczewski, L.3
  • 267
    • 0033760493 scopus 로고    scopus 로고
    • Overexpression of matrix metalloproteinase 2 predicts unfavorable outcome in early-stage non-small cell lung cancer
    • Passlick B, Sienel W, Seen-Hibler R, et al. Overexpression of matrix metalloproteinase 2 predicts unfavorable outcome in early-stage non-small cell lung cancer. Clin Cancer Res 2000; 6:3944-3948
    • (2000) Clin Cancer Res , vol.6 , pp. 3944-3948
    • Passlick, B.1    Sienel, W.2    Seen-Hibler, R.3
  • 268
    • 0034097012 scopus 로고    scopus 로고
    • Increased vascular endothelial growth factor and vascular endothelial growth factor-c and decreased nm23 expression associated with microdissemination in the lymph nodes in stage I non-small cell lung cancer
    • Ohta Y, Nozawa H, Tanaka Y, et al. Increased vascular endothelial growth factor and vascular endothelial growth factor-c and decreased nm23 expression associated with microdissemination in the lymph nodes in stage I non-small cell lung cancer. Thorac Cardiovasc Surg 2000; 119:804-813
    • (2000) Thorac Cardiovasc Surg , vol.119 , pp. 804-813
    • Ohta, Y.1    Nozawa, H.2    Tanaka, Y.3
  • 269
    • 0033626566 scopus 로고    scopus 로고
    • Prognostic significance of p27KIP1 protein and ki-67 growth fraction in non-small cell lung cancers
    • Hommura F, Dosaka-Akita H, Mishina T, et al. Prognostic significance of p27KIP1 protein and ki-67 growth fraction in non-small cell lung cancers. Clin Cancer Res 2000; 6:4073-4081
    • (2000) Clin Cancer Res , vol.6 , pp. 4073-4081
    • Hommura, F.1    Dosaka-Akita, H.2    Mishina, T.3
  • 270
    • 0033981030 scopus 로고    scopus 로고
    • Antineural and antinuclear autoantibodies are of prognostic relevance in non-small cell lung cancer
    • Blaes F, Klotz M, Huwer H, et al. Antineural and antinuclear autoantibodies are of prognostic relevance in non-small cell lung cancer. Ann Thorac Surg 2000; 69:254-258
    • (2000) Ann Thorac Surg , vol.69 , pp. 254-258
    • Blaes, F.1    Klotz, M.2    Huwer, H.3
  • 271
    • 0033793914 scopus 로고    scopus 로고
    • Prognostic factors in patients with surgically resected stages I and II non-small cell lung cancer
    • Jazieh AR, Hussain M, Howington JA, et al. Prognostic factors in patients with surgically resected stages I and II non-small cell lung cancer. Ann Thorac Surg 2000; 70:1168-1171
    • (2000) Ann Thorac Surg , vol.70 , pp. 1168-1171
    • Jazieh, A.R.1    Hussain, M.2    Howington, J.A.3
  • 272
    • 0034531389 scopus 로고    scopus 로고
    • Neopterin: A prognostic variable in operations for lung cancer
    • Prommegger R, Widner B, Murr C, et al. Neopterin: a prognostic variable in operations for lung cancer. Ann Thorac Surg 2000; 70:1861-1864
    • (2000) Ann Thorac Surg , vol.70 , pp. 1861-1864
    • Prommegger, R.1    Widner, B.2    Murr, C.3
  • 273
    • 0034307043 scopus 로고    scopus 로고
    • Ki-67 immunostaining and other prognostic factors including tobacco smoking in patients with resected nonsmall cell lung carcinoma
    • Shiba M, Kohno H, Kakizawa K, et al. Ki-67 immunostaining and other prognostic factors including tobacco smoking in patients with resected nonsmall cell lung carcinoma. Cancer 2000; 89:1457-1465
    • (2000) Cancer , vol.89 , pp. 1457-1465
    • Shiba, M.1    Kohno, H.2    Kakizawa, K.3
  • 274
    • 0033946522 scopus 로고    scopus 로고
    • MDM2 mRNA expression is a favorable prognostic factor in non-small-cell lung cancer
    • Ko JL, Cheng YW, Chang SL, et al. MDM2 mRNA expression is a favorable prognostic factor in non-small-cell lung cancer. Int J Cancer 2000; 89:265-270
    • (2000) Int J Cancer , vol.89 , pp. 265-270
    • Ko, J.L.1    Cheng, Y.W.2    Chang, S.L.3
  • 275
    • 0034693631 scopus 로고    scopus 로고
    • Correlation of total VEGF mRNA and protein expression with histologic type, tumor angiogenesis, patient survival and timing of relapse in non-small-cell lung cancer
    • Yuan A, Yu CJ, Chen WJ, et al. Correlation of total VEGF mRNA and protein expression with histologic type, tumor angiogenesis, patient survival and timing of relapse in non-small-cell lung cancer. Int J Cancer 2000; 89:475-483
    • (2000) Int J Cancer , vol.89 , pp. 475-483
    • Yuan, A.1    Yu, C.J.2    Chen, W.J.3
  • 276
    • 0034692447 scopus 로고    scopus 로고
    • Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer
    • Tang X, Khuri FR, Lee JJ, et al. Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer. J Natl Cancer Inst 2000; 92:1511-1516
    • (2000) J Natl Cancer Inst , vol.92 , pp. 1511-1516
    • Tang, X.1    Khuri, F.R.2    Lee, J.J.3
  • 277
    • 0033694997 scopus 로고    scopus 로고
    • Interleukin-8 messenger ribonucleic acid expression correlates with tumor progression, tumor angiogenesis, patient survival, and timing of relapse in non-small-cell lung cancer
    • Yuan A, Yang PC, Yu CJ, et al. Interleukin-8 messenger ribonucleic acid expression correlates with tumor progression, tumor angiogenesis, patient survival, and timing of relapse in non-small-cell lung cancer. Am J Respir Crit Care Med 2000; 162:1957-1963
    • (2000) Am J Respir Crit Care Med , vol.162 , pp. 1957-1963
    • Yuan, A.1    Yang, P.C.2    Yu, C.J.3
  • 278
    • 0035866413 scopus 로고    scopus 로고
    • Prognostic significance of polysialic acid expression in resected non-small cell lung cancer
    • Tanaka F, Otake Y, Nakagawa T, et al. Prognostic significance of polysialic acid expression in resected non-small cell lung cancer. Cancer Res 2001; 61:1666-1670
    • (2001) Cancer Res , vol.61 , pp. 1666-1670
    • Tanaka, F.1    Otake, Y.2    Nakagawa, T.3
  • 279
    • 0035863322 scopus 로고    scopus 로고
    • Cyclin E is the only cyclin-dependent kinase 2-associated cyclin that predicts metastasis and survival in early stage non-small cell lung cancer
    • Muller-Tidow C, Metzger R, Kugler K, et al. Cyclin E is the only cyclin-dependent kinase 2-associated cyclin that predicts metastasis and survival in early stage non-small cell lung cancer. Cancer Res 2001; 61:647-653
    • (2001) Cancer Res , vol.61 , pp. 647-653
    • Muller-Tidow, C.1    Metzger, R.2    Kugler, K.3
  • 280
    • 0034974069 scopus 로고    scopus 로고
    • Prognostic markers in resectable non-small cell lung cancer: A multivariate analysis
    • Pelletier MP, Edwardes MD, Michel RP, et al. Prognostic markers in resectable non-small cell lung cancer: a multivariate analysis. Can J Surg 2001; 44:180-188
    • (2001) Can J Surg , vol.44 , pp. 180-188
    • Pelletier, M.P.1    Edwardes, M.D.2    Michel, R.P.3
  • 281
    • 0034949214 scopus 로고    scopus 로고
    • A biological staging model for operable non-small cell lung cancer
    • Cox G, Jones JL, Andi A, et al. A biological staging model for operable non-small cell lung cancer. Thorax 2001; 56:561-566
    • (2001) Thorax , vol.56 , pp. 561-566
    • Cox, G.1    Jones, J.L.2    Andi, A.3
  • 282
    • 0035863288 scopus 로고    scopus 로고
    • Vascular endothelial growth factor 189 mRNA isoform expression specifically correlates with tumor angiogenesis, patient survival, and postoperative relapse in non-small-cell lung cancer
    • Yuan A, Yu CJ, Kuo SH, et al. Vascular endothelial growth factor 189 mRNA isoform expression specifically correlates with tumor angiogenesis, patient survival, and postoperative relapse in non-small-cell lung cancer. J Clin Oncol 2001; 19:432-441
    • (2001) J Clin Oncol , vol.19 , pp. 432-441
    • Yuan, A.1    Yu, C.J.2    Kuo, S.H.3
  • 283
    • 0035863302 scopus 로고    scopus 로고
    • Lack of prognostic significance of p53 and K-ras mutations in primary resected non-small-cell lung cancer on E4592: A Laboratory Ancillary Study on an Eastern Cooperative Oncology Group prospective randomized trial of postoperative adjuvant therapy
    • Schiller JH, Adak S, Feins RH, et al. Lack of prognostic significance of p53 and K-ras mutations in primary resected non-small-cell lung cancer on E4592: a Laboratory Ancillary Study on an Eastern Cooperative Oncology Group prospective randomized trial of postoperative adjuvant therapy. J Clin Oncol 2001; 19:448-457
    • (2001) J Clin Oncol , vol.19 , pp. 448-457
    • Schiller, J.H.1    Adak, S.2    Feins, R.H.3
  • 284
    • 0035040809 scopus 로고    scopus 로고
    • Diagnostic and prognostic significance of squamous cell carcinoma antigen in non-small cell lung cancer
    • Vassilakopoulos T, Troupis T, Sotiropoulou C, et al. Diagnostic and prognostic significance of squamous cell carcinoma antigen in non-small cell lung cancer. Lung Cancer 2001; 32:137-144
    • (2001) Lung Cancer , vol.32 , pp. 137-144
    • Vassilakopoulos, T.1    Troupis, T.2    Sotiropoulou, C.3
  • 285
    • 0035834870 scopus 로고    scopus 로고
    • Combined analysis of MIB-1 and thyroid transcription factor-1 predicts survival in non-small cell lung carcinomas
    • Puglisi F, Aprile G, Bruckbauer M, et al. Combined analysis of MIB-1 and thyroid transcription factor-1 predicts survival in non-small cell lung carcinomas. Cancer Lett 2001; 162:97-103
    • (2001) Cancer Lett , vol.162 , pp. 97-103
    • Puglisi, F.1    Aprile, G.2    Bruckbauer, M.3
  • 286
    • 0035155064 scopus 로고    scopus 로고
    • Vascular endothelial growth factor expression in stage I non-small cell lung cancer correlates with neoangiogenesis and a poor prognosis
    • Han H, Silverman JF, Santucci TS, et al. Vascular endothelial growth factor expression in stage I non-small cell lung cancer correlates with neoangiogenesis and a poor prognosis. Ann Surg Oncol 2001; 8:72-79
    • (2001) Ann Surg Oncol , vol.8 , pp. 72-79
    • Han, H.1    Silverman, J.F.2    Santucci, T.S.3
  • 287
    • 0035106231 scopus 로고    scopus 로고
    • Autocrine motility factor receptor expression in patients with stage I non-small cell lung cancer
    • Kara M, Ohta Y, Tanaka Y, et al. Autocrine motility factor receptor expression in patients with stage I non-small cell lung cancer. Ann Thorac Surg 2001; 71:944-948
    • (2001) Ann Thorac Surg , vol.71 , pp. 944-948
    • Kara, M.1    Ohta, Y.2    Tanaka, Y.3
  • 288
    • 0035059312 scopus 로고    scopus 로고
    • Visceral pleura invasion by non-small cell lung cancer: An underrated bad prognostic factor
    • Manac'h D, Riquet M, Medioni J, et al. Visceral pleura invasion by non-small cell lung cancer: an underrated bad prognostic factor. Ann Thorac Surg 2001; 71:1088-1093
    • (2001) Ann Thorac Surg , vol.71 , pp. 1088-1093
    • Manac'h, D.1    Riquet, M.2    Medioni, J.3
  • 289
    • 0035878613 scopus 로고    scopus 로고
    • Expression of tumor-associated antigen RCAS1 correlates significantly with poor prognosis in nonsmall cell lung carcinoma
    • Izumi M, Nakanishi Y, Yoshino I, et al. Expression of tumor-associated antigen RCAS1 correlates significantly with poor prognosis in nonsmall cell lung carcinoma. Cancer 2001; 92:446-451
    • (2001) Cancer , vol.92 , pp. 446-451
    • Izumi, M.1    Nakanishi, Y.2    Yoshino, I.3
  • 290
    • 0035871403 scopus 로고    scopus 로고
    • Patterns of angiogenesis in nonsmall-cell lung carcinoma
    • Offersen BV, Pfeiffer P, Hamilton-Dutoit S, et al. Patterns of angiogenesis in nonsmall-cell lung carcinoma. Cancer 2001; 91:1500-1509
    • (2001) Cancer , vol.91 , pp. 1500-1509
    • Offersen, B.V.1    Pfeiffer, P.2    Hamilton-Dutoit, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.